Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017918	s-cmvab	— (—)	10393	15432	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

2672

6157

2.40

321.77

1.6

1.4

—

All pneumoniae

2600

7280

2.37

319.74

1.7

1.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

2607

5996

2.42

318.02

1.6

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

562

966

6.23

314.85

1.3

1.5

—

Pneumonia, organism unspecified

2298

6509

2.48

314.47

1.7

1.4

—

Polycystic kidney disease

287

223

17.57

313.03

2.7

1.4

—

Glomerular disorders in diseases classified elsewhere

863

891

11.45

307.65

2.7

1.3

—

Cystic kidney disease, including avohilmo

325

281

14.84

307.65

2.7

1.4

—

Diseases of liver

1410

2992

5.03

307.65

1.3

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3141

6197

3.32

307.65

2.1

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3310

6156

3.77

307.65

1.7

1.4

—

Implicit Sepsis, including avohilmo

2179

5465

2.93

307.65

1.7

1.3

—

Acute renal failure

916

1351

7.31

307.65

2.0

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

764

736

11.77

307.65

1.4

1.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2268

5033

2.70

307.65

1.6

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2292

6019

2.63

307.65

1.7

1.4

—

Transplanted organ and tissue status

2060

700

55.88

307.65

2.7

1.2

—

Heart failure, not strict

2414

3871

4.39

307.65

2.1

1.3

—

Other septicaemia, including avohilmo

1352

2534

5.28

307.65

2.2

1.3

—

All chronic kidney diseases

2333

3480

5.69

307.65

2.4

1.2

—

General symptoms and signs

2920

4601

3.27

307.65

1.5

1.4

—

Other septicaemia

1327

2481

5.31

307.65

2.2

1.3

—

2268

5033

2.70

307.65

1.6

1.4

—

Anaemias

1069

1072

6.84

307.65

2.0

1.2

—

GASTRO-related operations

2187

2627

4.30

307.65

1.6

1.2

—

Liquid cancers

1740

1865

9.85

307.65

1.4

1.5

—

Diffuse large B-cell lymphoma, including Hilmo

322

261

14.56

307.65

1.5

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

2584

7098

2.43

307.65

1.7

1.4

—

Non-follicular lymphoma

555

624

10.17

307.65

1.4

—

Diffuse large B-cell lymphoma

322

261

14.56

307.65

1.5

1.3

—

Hypertensive diseases (excluding secondary)

1440

2554

3.39

307.65

2.2

1.2

—

Nephropathy related operations

1851

871

32.30

307.65

2.7

1.2

—

Implicit Sepsis

2090

4924

3.23

307.65

1.8

1.3

—

Explicit Sepsis, including avohilmo

1527

3249

4.46

307.65

2.1

1.3

—

Persons encountering health services for specific procedures and health care

3364

6208

3.31

307.65

1.9

1.2

—

Renal tubulo-interstitial diseases

2880

6068

3.62

307.65

2.1

1.2

—

Liquid cancers, including Hilmo

1829

2229

7.90

307.65

1.4

1.5

—

Inflammatory bowel disease treatment related agents

3110

6691

2.64

307.65

1.6

1.5

—

Dental caries

1334

1966

6.97

307.65

2.2

1.3

—

Other dialysis

556

260

40.21

307.65

2.9

1.5

—

Preparatory care for dialysis

668

307

35.42

307.65

2.6

1.3

—

Implicit viral Sepsis

840

1498

6.00

307.65

2.1

1.3

—

Donors of organs and tissues

249

104

39.59

307.65

1.7

1.2

—

Other bacterial diseases

2975

5705

3.58

307.65

1.8

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

3633

5137

4.08

307.65

1.9

1.2

—

Cytomegalovirus infection, IBD co-morbidity

370

195

31.89

307.65

2.4

1.6

—

Bacterial infection, other or unspecified

2054

3370

5.44

307.65

1.8

1.3

—

Cystic kidney disease

323

269

15.80

307.65

2.7

1.4

—

Fever of other and unknown origin

2706

3808

6.58

307.65

1.6

1.4

—

Secondary hypertension

719

455

18.98

307.65

2.8

1.2

—

Implicit viral Sepsis, including avohilmo

1046

2313

4.75

307.65

2.0

1.3

—

Explicit Sepsis

1497

3187

4.48

307.65

2.1

1.3

—

Other diseases of blood and blood-forming organs, wide

926

1828

5.46

307.65

1.5

1.4

—

Disorders resulting from impaired renal tubular function

463

267

25.18

307.65

3.0

1.4

—

Implicit bacterial Sepsis, including avohilmo

1411

2774

4.42

307.65

1.8

1.3

—

Unspecified kidney failure

431

538

8.69

307.65

2.4

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

488

518

10.70

307.65

1.4

1.5

—

First line medication for Crohn's disease

3581

5293

3.77

307.65

1.8

1.2

—

Malaise and fatigue

1279

2988

3.47

307.65

1.4

—

Oral corticosteroids

2689

6369

2.53

307.65

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2219

5580

2.83

307.65

1.7

1.4

—

Bacterial Sepsis

1489

2943

4.37

307.65

1.8

1.3

—

All kidney diseases

3027

6582

3.18

307.65

2.1

1.2

—

Azathioprine

755

1307

6.33

307.65

2.2

1.5

—

Viral Sepsis

844

1500

6.02

307.65

2.1

1.3

—

Certain infectious and parasitic diseases

2312

4146

2.86

307.65

1.6

1.3

—

Renal failure

2329

2749

7.83

307.65

2.4

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

322

261

14.56

307.65

1.5

1.3

—

Other/unspecified cytomegaloviral diseases

340

170

35.76

307.65

2.5

1.5

—

L04AA Selective immunosuppressants

1848

1899

11.54

307.65

2.5

1.2

—

Dialysis, with operation codes

1837

855

31.60

307.65

2.7

1.2

—

Other and unspecified anaemias

1146

3051

3.65

307.65

1.7

1.4

—

Aplastic and other anaemias

1381

3289

4.00

307.65

1.8

1.4

—

L04AD Calcineurin inhibitors

1890

880

35.17

307.65

2.7

1.2

—

L04AX Other immunosuppressants

1649

5717

2.99

307.65

1.7

1.4

—

Enlarged lymph nodes

800

1047

8.36

307.65

1.4

—

Other anaemias

1152

3071

3.64

307.65

1.7

1.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

1607

1586

11.62

307.65

1.4

1.5

—

Cytomegaloviral disease

371

198

30.64

307.65

2.4

1.6

—

ILD medications: immunosuppressive drugs

3316

4664

6.94

307.65

2.1

1.2

—

Chronic kidney disease

1935

1882

11.06

307.65

2.6

1.2

—

Infections, IBD-co-morbidities

765

750

7.73

307.65

2.0

1.3

—

Cytomegaloviral disease, including avohilmo

383

198

31.98

307.65

2.4

1.6

—

Dialysis

716

285

45.07

307.65

3.2

1.3

—

ILD medications: azathioprine

755

1043

7.96

307.65

2.2

1.2

—

Any gastric operation

2187

2627

4.30

307.65

1.6

1.2

—

Implicit bacterial Sepsis

1335

2510

4.77

307.65

1.9

1.3

—

Secondary uncertain malignant neoplasm

544

770

7.64

307.65

1.3

1.5

—

Kidney transplant status

1218

427

65.98

307.65

3.3

1.3

—

Glomerular diseases

1152

1465

8.96

307.65

2.8

1.3

—

Glomerulonephritis

525

794

7.40

307.65

2.9

1.5

—

Bacterial infection, other or unspecified, including avohilmo

2168

3729

5.02

307.65

1.8

1.3

—

Septicaemia

1447

2772

5.00

307.65

2.1

1.3

—

Other bacterial diseases, including avohilmo

3003

6108

3.17

307.65

1.8

1.4

—

Influenza and pneumonia

2763

7164

2.44

307.65

1.7

1.4

—

Care involving dialysis

1362

504

44.36

307.65

2.9

1.3

—

Other disorders of kidney and ureter

616

1000

6.78

307.65

2.7

1.4

—

Extracorporeal dialysis

969

441

35.89

307.65

3.1

1.4

—

ILD medications

3845

5311

4.05

307.65

1.9

1.2

—

Second line medication for Crohn's disease

1751

5911

3.07

307.65

1.7

1.4

—

Caries of dentine

1165

1764

6.93

307.65

2.1

1.3

—

Failure and rejection of transplanted organs and tissues

279

120

48.48

307.65

2.7

1.6

—

Other viral diseases

1119

3376

3.48

302.04

2.0

1.5

—

Covid-19 confirmed case

1116

3365

3.45

301.03

1.8

1.4

—

Non-Hodgkin lymphoma, all

278

211

15.29

300.57

1.4

1.3

—

Diabetic nephropathy

637

1300

5.24

291.36

2.6

1.4

—

Diabetic nephropathy, excluding more controls

633

1003

5.58

289.73

2.6

1.4

—

Heart failure and antihypertensive medication

757

1029

5.01

289.06

2.0

1.2

—

Agranulocytosis

504

857

6.45

287.37

1.6

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2470

7303

2.30

285.57

1.7

1.4

—

Acute myeloid leukaemia and myelodysplastic syndromes

209

102

25.86

284.33

1.4

—

Congenital malformations of the urinary system

402

563

8.36

279.75

2.7

1.6

—

Multiple myeloma, including Hilmo

265

216

14.18

274.41

1.6

1.3

—

Congenital malformations of the urinary system, including avohilmo

407

595

7.92

271.94

2.7

1.6

—

Myeloid leukaemia

244

184

16.97

268.48

1.4

—

Other medical care

1118

2973

3.25

264.95

1.4

1.2

—

Other viral diseases, including avohilmo

1295

4549

2.93

264.60

1.9

1.5

—

Hypertensive diseases

1853

4135

2.59

262.36

2.1

1.2

—

Hypertension

1852

4132

2.59

262.22

2.1

1.2

—

Other disorders involving the immune mechanism, not elsewhere classified

286

298

12.12

255.33

2.6

1.6

—

Acute peritonitis

339

433

8.81

253.21

2.7

1.4

—

Other diseases of liver

639

1494

4.54

250.64

1.4

1.5

—

Codes for special purposes

1451

5561

2.66

249.55

1.8

1.4

—

Provisional assignment of new diseases of uncertain etiology

1450

5558

2.66

249.36

1.8

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

1747

3972

2.58

246.78

1.9

1.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

273

280

12.40

246.78

2.7

1.6

—

Other heart diseases

1247

2762

3.02

243.44

1.9

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

399

367

8.11

243.27

1.4

1.3

—

Anaemia in chronic diseases classified elsewhere

215

156

17.50

241.54

2.6

1.5

—

Intestinal infectious diseases

2294

7963

2.18

241.09

1.8

1.4

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

548

1201

4.89

233.98

1.5

—

Autoimmune hepatitis, wide definition

269

284

10.80

233.77

1.2

1.4

—

Heart failure,strict

1108

2547

3.12

233.69

1.8

1.2

—

Acute myeloid leukaemia, helper endpoint

152

36.94

229.52

1.4

—

Acute myeloid leukaemia

152

36.94

229.52

1.4

—

Acute myeloid leukaemia, including Hilmo

152

36.94

229.52

1.4

—

Coagulation defects, purpura and other haemorrhagic conditions

679

1778

4.04

228.43

1.6

1.4

—

Certain disorders involving the immune mechanism

661

1712

4.09

226.14

2.0

1.5

—

Autoimmune diseases

2540

6189

2.12

225.57

1.6

1.4

—

Multiple myeloma and malignant plasma cell neoplasms

264

286

10.56

225.26

1.6

1.4

—

Chronic nephritic syndrome

257

275

11.03

222.54

2.9

1.3

—

Fibrosis and cirrhosis of liver

345

522

7.27

220.81

1.5

1.4

—

Lung transplantation

156

43.52

220.41

1.7

1.5

—

Hernia of abdominal wall, postoperative

402

693

5.96

220.32

1.9

1.2

—

Purpura and other haemorrhagic conditions

519

1143

4.86

220.26

1.5

—

Lung transplant status

155

43.85

219.59

1.7

1.5

—

Gout, FINNGEN

727

2039

3.67

217.08

1.9

1.4

—

ILD, hospital admission 2, with pulmonary infections

340

513

7.09

216.67

1.4

1.3

—

Hyperparathyroidism

523

1155

4.70

215.93

2.6

1.3

—

Other inflammatory liver diseases

321

462

7.73

215.65

1.3

1.5

—

Used for control exclusion in common control thyroid runs

2398

5819

2.11

211.29

1.6

1.4

—

Abnormal findings on examination of blood, without diagnosis

1181

4012

2.74

211.25

1.5

—

Lymphoid leukaemia

302

418

8.20

211.02

1.2

1.5

—

Any reimbursement code in KELA

1390

2609

2.73

210.37

1.6

1.2

—

Metabolic disorders

2086

5817

2.19

210.32

1.8

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

1747

7008

2.27

210.09

1.9

1.4

—

Multiple myeloma

182

125

17.18

208.63

1.6

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

182

125

17.18

208.63

1.6

1.2

—

Cardiovascular diseases

1649

3641

2.46

207.35

1.9

1.2

—

Gout

727

1769

3.66

207.22

1.9

1.4

—

Disorders of parathyroid gland

562

1362

4.26

205.31

2.5

1.3

—

IgA nephropathy (IgA glomerulonephritis)

215

204

13.44

205.14

2.9

1.4

—

Examination and observation for other reasons

1353

2929

2.66

203.41

1.6

1.3

—

Malignant neoplasm

1837

4805

2.28

202.64

1.5

—

Malignant neoplasm

1837

4810

2.28

202.18

1.5

—

Autoimmune diseases related-to ILD

1955

7751

2.15

201.83

1.4

1.5

—

Nephrotic syndrome

237

267

10.78

198.53

3.4

1.6

—

Intrahepatic Cholestasis of Pregnancy (ICP)

364

651

6.20

197.80

1.2

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

364

663

6.08

194.02

1.2

1.3

—

Malignant neoplasm, including Hilmo

1870

4992

2.22

193.71

1.5

—

Thrombocytopenia, unspecified

326

533

6.72

193.65

1.4

1.5

—

Nausea and vomiting

755

2290

3.33

192.75

1.9

1.4

—

Headache

1357

4315

2.47

192.50

1.4

—

Hypertension, essential

1601

3903

2.36

189.20

1.8

1.2

—

Certain infectious and parasitic diseases, including avohilmo

1409

2812

2.55

189.04

1.5

1.3

—

Malignant neoplasm, wide definition

1859

5003

2.20

188.55

1.5

—

All influenza

715

2202

3.37

186.81

1.9

1.5

—

Cirrhosis of liver, NAS

270

378

8.00

186.35

1.4

—

Chronic lymphocytic leukaemia, helper endpoint

175

137

14.82

185.83

1.1

1.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

175

137

14.82

185.83

1.1

1.2

—

Chronic lymphocytic leukaemia

175

137

14.82

185.83

1.1

1.2

—

Diseases of peritoneum

375

728

5.53

184.82

2.6

1.4

—

Hepatic failure, not elsewhere classified

218

239

10.50

184.63

1.4

1.5

—

Acute upper respiratory infections of multiple and unspecified sites

1800

6194

2.16

183.73

1.6

1.4

—

Other respiratory diseases principally affecting the interstitium

492

1192

4.32

183.55

1.5

1.4

—

Oxycodone

879

2577

2.99

183.20

1.6

1.4

—

Percutaneous Coronary Intervention

1615

4373

2.29

181.41

1.8

1.4

—

Other disorders of fluid, electrolyte and acid-base balance

733

2181

3.26

180.47

2.0

1.3

—

Coronary revascularization (ANGIO or CABG)

1614

4373

2.29

180.46

1.8

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

288

444

6.94

179.92

1.4

1.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

377

756

5.43

179.90

1.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

377

760

5.40

178.82

1.3

—

Bronchitis

2363

7361

1.96

177.16

1.6

1.4

—

COPD/asthma/ILD related infections

2067

5033

2.09

177.06

1.5

1.4

—

COPD/asthma related infections

2067

5033

2.09

177.06

1.5

1.4

—

Care involving use of rehabilitation procedures

1271

4823

2.41

176.75

1.8

1.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

559

974

4.09

174.08

2.2

1.2

—

Ascites

288

461

6.74

173.94

1.5

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1394

5357

2.31

173.71

1.5

—

Cholangitis (primary sclerosing, PSC)

280

438

7.01

173.58

1.7

1.5

—

Rare circulating lymphoid malignancy, including Hilmo

200

215

11.00

172.67

1.4

1.6

—

Emergency coronary revascularization (for ACS)

1679

4688

2.20

171.80

1.8

1.4

—

Ischemic heart diseases

1662

4573

2.20

169.82

1.8

1.4

—

Primary Sclerosing Cholangitis, IBD and UDCA required

188

196

11.90

167.37

1.6

1.7

—

Hard cardiovascular diseases

1681

4653

2.17

165.84

1.8

1.4

—

Gastrointestinal diseases

1265

2558

2.52

165.79

1.6

1.3

—

Other interstitial pulmonary diseases

424

994

4.48

165.40

1.4

—

Interstitial lung disease

424

997

4.47

164.75

1.4

—

Interstitial lung disease endpoints

424

997

4.47

164.75

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2183

7296

1.95

164.66

1.7

1.4

—

ILD, hospital admissions

421

986

4.49

164.49

1.4

—

Major coronary heart disease event

1655

4631

2.18

164.37

1.8

1.4

—

Acute tubulo-interstitial nephritis

1288

4748

2.33

163.61

1.9

1.2

—

Medical observation and evaluation for suspected diseases and conditions

1360

2941

2.41

162.55

1.6

1.3

—

Oedema, not elsewhere classified

646

1982

3.26

161.61

1.6

1.4

—

Tramadol

1625

4569

2.17

161.59

1.6

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

600

1774

3.47

159.80

2.5

1.6

—

Heart failure, strict

1148

3297

2.47

157.89

1.8

1.4

—

General examination and investigation of persons without complaint and reported diagnosis

1328

2939

2.39

157.05

1.7

1.3

—

ILD, hospital admissions 1, main diag only

390

898

4.58

155.94

1.4

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2385

7203

1.87

154.24

1.6

1.4

—

Antihypertensive medication - note that there are other indications

1544

3727

2.21

152.80

1.9

1.3

—

Insulin, fast-acting

912

3587

2.62

151.98

2.1

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

610

1883

3.32

151.71

2.5

1.6

—

Other heart diseases, wide

2017

6342

1.96

151.67

1.7

1.4

—

Any death

1258

3875

2.32

150.61

1.5

—

Polyarthropathies

1544

4715

2.14

150.18

1.7

1.5

—

Disorders of other endocrine glands

1096

4638

2.39

149.79

2.1

1.4

—

Any event in cancer register

1913

5708

1.99

149.56

1.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2277

6519

1.88

148.49

1.7

1.4

—

Noninfective enteritis and colitis

1139

5003

2.33

148.05

1.5

—

Heart failure and coronary heart disease

839

2158

2.79

146.49

1.8

1.3

—

Complications of surgical and medical care, not elsewhere classified

2064

7348

1.90

146.43

1.8

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

940

2284

2.65

145.04

1.7

1.2

—

Persons encountering health services in other circumstances, wide

2327

6527

1.86

144.69

1.7

1.4

—

Insulin, fast-acting or short human

914

3702

2.54

143.15

2.1

1.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1313

5584

2.17

142.62

2.0

1.4

—

Oesophageal varices

210

300

7.88

142.59

1.5

—

Viral pneumonia

395

985

4.21

142.10

1.9

1.4

—

Opioids

2033

5518

1.93

141.85

1.4

—

Dependence on enabling machines and devices, not elsewhere classified

124

19.04

141.52

4.3

1.1

—

Hypertensive Renal Disease

161

167

10.58

140.83

2.5

1.2

—

Excluding asthma or asthma-COPD overlap

1542

3669

2.14

140.31

1.5

1.4

—

Other pulmonary diagnosis

1541

3669

2.14

139.99

1.5

1.4

—

All-cause Heart Failure

1087

3222

2.39

139.87

1.8

1.4

—

Complications of medical and surgical care

1523

6827

2.04

139.82

1.8

1.4

—

2239

6185

1.86

139.24

1.5

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

725

1185

3.13

139.02

1.5

1.3

—

Systemic connective tissue disorders

777

2954

2.70

138.75

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1303

2941

2.28

138.56

1.6

1.3

—

Insulin medication

1313

5153

2.16

137.13

2.0

1.4

—

COPD differential diagnosis

1529

3666

2.12

136.52

1.5

1.4

—

ILD differential diagnosis

1529

3666

2.12

136.50

1.5

1.4

—

Bleeding

1641

5857

2.00

135.35

1.8

1.4

—

Implicit fungal Sepsis, including avohilmo

247

441

5.99

133.34

2.0

1.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

186

250

8.27

132.90

1.3

—

Endocrine, nutritional and metabolic diseases

1731

4452

1.99

131.39

1.7

1.3

—

Symptoms and signs involving the digestive system and abdomen

2014

5419

1.89

130.83

1.6

1.4

—

Acute upper respiratory infections

2076

6855

1.84

130.04

1.5

1.4

—

445

1283

3.63

129.90

1.7

1.3

—

Idiopathic pulmonary fibrosis

239

431

5.91

127.53

1.4

1.3

—

Atrial fibrillation and flutter

606

1273

3.14

127.40

1.7

1.2

—

Other bacterial intestinal infections

463

1385

3.47

127.12

1.7

1.4

—

Budesonide

423

1197

3.69

126.94

1.3

1.4

—

Fungal Sepsis

186

264

7.75

126.43

2.0

1.3

—

Hyperkalaemia

206

325

6.79

126.08

2.5

1.3

—

Maternal care for other conditions predominantly related to pregnancy

606

2081

2.95

125.34

1.3

1.4

—

Erysipelas

961

3595

2.34

124.42

1.8

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1000

4485

2.28

123.96

1.8

1.5

—

Neoplasms

1712

4690

1.95

122.56

1.6

1.4

—

Implicit fungal Sepsis

174

238

8.07

122.29

2.0

1.3

—

Chronic hepatitis, not elsewhere classified

171

231

8.31

121.94

1.2

1.4

—

Follicular lymphoma, hilmo

184

270

7.56

121.62

1.4

1.3

—

Other disorders of white blood cells

221

390

6.18

121.48

1.4

—

Haemolytic anaemias

181

265

7.70

120.31

1.6

1.5

—

Myelodysplastic syndrome, including Hilmo

130

125

11.51

120.17

1.4

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1217

5837

2.08

119.96

1.8

1.4

—

Acquired haemolytic anaemia

144

171

9.76

114.96

1.7

1.4

—

Other viral diseases, not elsewhere classified

543

1890

2.98

114.89

2.0

1.5

—

Bacterial intestinal infections, IBD co-morbidities

457

1445

3.28

114.71

1.8

1.4

—

Genitourinary diseases

1248

2974

2.14

113.87

1.9

1.2

—

Alcoholic liver disease

305

743

4.34

113.66

1.2

1.5

—

Ulcer of lower limb, not elsewhere classified

362

994

3.79

113.45

2.2

1.4

—

Asthma, excluding more controls

1349

3405

2.06

113.14

1.5

1.4

—

Erysipelas, including avohilmo

1230

4477

2.06

113.13

1.7

1.3

—

Abnormalities of breathing

1850

5865

1.83

112.70

1.5

1.4

—

Type 2 diabetes, wide definition

1446

4700

1.97

112.40

1.8

1.4

—

Inflammatory bowel disease

799

3414

2.41

111.64

1.4

1.5

—

Reimbursement for rheumatic diseases

1150

5634

2.07

111.43

1.5

—

Pain, not elsewhere classified

561

2018

2.84

111.35

1.5

1.4

—

Pneumocystosis, including avohilmo

128

137

11.21

111.25

1.6

1.4

—

Pneumocystosis

128

137

11.21

111.25

1.6

1.4

—

Other disorders of skin and subcutaneous tissue

1408

6240

1.93

110.25

1.8

1.4

—

Insulin, intermediate and long-acting

1103

5177

2.09

110.23

1.9

1.4

—

Abnormal serum enzyme levels

670

2555

2.60

109.99

1.4

1.5

—

Drug-induced neutropenia

250

538

4.99

109.61

1.5

1.3

—

Disorders of lens

1259

3888

2.04

107.59

2.0

1.4

—

Type 1 diabetes

659

2627

2.58

106.92

2.3

1.5

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1874

8407

1.76

106.83

1.6

1.5

—

Abnormal findings on diagnostic imaging of lung

873

3711

2.27

106.78

1.5

1.4

—

Leukaemia of unspecified cell type

18.41

106.41

1.3

—

Other bacterial intestinal infections, including avohilmo

544

1982

2.83

105.86

1.7

1.3

—

Mantle cell lymphoma, including Hilmo

17.12

105.78

1.4

1.3

—

5-aminosalicylic acid

537

1949

2.84

105.43

1.3

1.5

—

Non-invasive ventilation

546

1698

2.84

104.58

1.8

1.3

—

Gout, idiopatic and unspecified

522

1873

2.87

104.56

1.9

1.4

—

Asthma

1377

3636

1.98

103.62

1.5

1.4

—

Autoimmune hepatitis

20.70

103.58

1.3

1.5

—

Diabetic maculopathy, excluding more controls

322

873

3.87

103.25

2.5

1.3

—

Cerebrovascular diseases (FINNGEN)

573

1451

2.83

103.19

1.7

1.2

—

Bacterial pneumoniae

773

2921

2.37

102.76

1.8

1.4

—

Asthma, unspecified (mode), excluding more controls

948

3121

2.21

102.61

1.4

—

Bacterial pneumonia (organism specified)

884

3669

2.22

101.88

1.7

1.4

—

Primary biliary cholangitis, wide definition

114

116

11.08

101.66

1.5

1.4

—

Diabetic retinopathy, strict definition

466

1404

3.09

101.41

2.4

1.5

—

Cardiomyopathy

400

1256

3.29

101.41

1.7

1.4

—

Other and unspecified disorders of white blood cells

168

271

6.81

101.35

1.4

—

Infections of the skin and subcutaneous tissue

1305

6835

1.91

101.02

1.8

1.5

—

IBD patients in KELA-register

623

2500

2.57

100.25

1.4

1.5

—

Osteopathies and chondropathies

1116

5141

2.02

100.15

1.7

1.4

—

Gout, unspecified

430

1427

3.11

99.31

1.9

1.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

180

314

6.05

99.30

1.4

1.3

—

Explicit bacterial Sepsis, including avohilmo

286

733

4.07

99.03

1.8

1.3

—

Gingival hyperplasia

184

334

6.15

98.93

3.5

1.5

—

Other viral diseases, not elsewhere classified, including avohilmo

715

3052

2.40

98.73

1.8

1.5

—

Dyspnoea

1722

7123

1.77

98.63

1.5

—

Other acute lower respiratory infections

1142

5574

1.99

98.45

1.8

1.5

—

Abdominal and pelvic pain

1878

5416

1.76

98.40

1.6

1.4

—

Mantle cell lymphoma

24.48

98.32

1.4

1.2

—

Bacterial pneumonia, not elsewhere classified

730

2745

2.38

98.22

1.7

1.4

—

Factors influencing health status and contact with health services

491

782

3.20

98.21

1.6

1.1

—

Diseases of oesophagus, stomach and duodenum

2042

7170

1.70

98.21

1.6

1.4

—

Symptoms and signs involving the circulatory and respiratory systems

2005

5888

1.73

97.95

1.5

1.4

—

Enterocolitis due to Clostridium difficile

284

731

4.06

97.85

1.9

1.4

—

Disorders of gallbladder, biliary tract and pancreas

1828

6598

1.74

97.37

1.5

1.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

146

212

7.59

97.34

1.6

1.4

—

Inflammatory bowel disease, strict (require KELA)

623

2537

2.54

97.18

1.4

1.5

—

Molar incisor enamel hypoplasia, with caries

113

127

13.18

97.14

4.5

1.6

—

Streptococcal septicaemia, including avohilmo

243

563

4.52

96.43

1.8

1.4

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

133

179

8.84

96.39

1.8

1.6

—

Hypoplasia of dental enamel

123

159

11.74

95.59

4.5

2.0

—

Hypertensive heart and/or renal disease

467

1158

3.01

95.15

2.3

1.2

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

158

254

6.64

94.97

1.4

1.3

—

Need for immunization against other single viral diseases

123

153

9.46

94.95

3.2

1.5

—

Other diseases of pleura

808

3189

2.24

94.48

1.6

1.4

—

Disorders of lipoprotein metabolism and other lipidaemias

1410

4643

1.87

93.72

1.7

1.4

—

Gout, strict definition

391

1271

3.18

93.70

2.0

1.4

—

Vitreous haemorrhage

291

789

3.88

93.42

2.5

1.4

—

Amputation

254

624

4.25

93.22

2.5

1.3

—

Explicit bacterial Sepsis

276

721

3.99

93.06

1.8

1.3

—

Atrial fibrillation and flutter with reimbursement

441

903

3.14

92.44

1.6

1.2

—

Asthma (mode)

1325

3666

1.92

92.41

1.4

—

Other diseases of intestines

2125

7213

1.66

92.16

1.6

1.5

—

Asthma, unspecified (mode)

957

3332

2.10

92.07

1.4

—

Solid cancers

1441

4625

1.85

91.87

1.5

—

Diseases of the digestive system

890

4263

2.11

91.46

1.7

1.4

—

Type 1 diabetes, wide definition, subgroup 1

551

2178

2.61

91.29

2.3

1.4

—

Diseases of arteries, arterioles and capillaries

1157

4406

1.95

91.21

2.0

1.4

—

Ulcerative colitis

611

2545

2.47

90.60

1.4

1.5

—

Asthma (only as main-diagnosis), excluding more controls

1197

3405

1.97

90.56

1.5

1.4

—

Streptococcal septicaemia

234

553

4.43

90.53

1.8

1.4

—

Solid cancers, including Hilmo

1488

4816

1.82

90.44

1.5

—

Diabetic retinopathy, excluding more controls

600

1294

2.68

90.36

2.2

1.4

—

Type 1 diabetes, wide definition

569

2301

2.55

89.77

2.3

1.5

—

Diseases of the skin and subcutaneous tissue

1848

5444

1.72

89.70

1.5

1.4

—

Symptoms and signs involving the skin and subcutaneous tissue

1409

7504

1.80

89.61

1.5

—

Other necrotizing vasculopathies

210

464

4.79

88.86

1.8

1.4

—

Hypothyroidism (congenital or acquired)

544

1123

2.77

88.35

1.5

1.2

—

Codeine

1719

5398

1.74

88.16

1.4

—

Drug-induced cataract

129

185

7.97

87.73

2.5

1.5

—

Nutritional anaemias

912

4310

2.05

86.42

1.7

1.4

—

Other diseases of biliary tract

233

570

4.28

86.21

1.6

1.4

—

Colitis, primary sclerosing

108

130

10.09

86.11

1.5

—

Congenital malformations, deformations and chromosomal abnormalities

1296

6850

1.82

86.03

1.9

1.4

—

Unspecified jaundice

160

287

5.93

86.00

1.6

1.4

—

Protozoal diseases

143

234

6.84

85.55

1.5

1.4

—

Sub-endpoint used in defining T1D endpoints

668

2913

2.31

85.35

2.3

1.5

—

Protozoal diseases, including avohilmo

146

246

6.62

84.78

1.5

1.4

—

Peripheral artery operations in Hilmo

272

751

3.74

84.41

2.4

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

148

251

6.24

84.20

1.4

—

Iron deficiency anaemia

811

3823

2.12

84.15

1.7

1.4

—

Persons encountering health services for examination and investigation

1138

2941

1.96

83.62

1.5

1.3

—

Asthma (only as main-diagnosis)

1216

3636

1.89

82.37

1.5

1.4

—

Hypothyroidism and >3 levothyroxin purchases

528

1117

2.70

82.17

1.4

1.2

—

Hypothyroidism, levothyroxine purchases

528

1117

2.70

82.17

1.4

1.2

—

Syncope and collapse

708

2682

2.23

82.10

1.4

—

Hepatocellular carcinoma, including Hilmo

113

149

8.27

81.86

1.4

1.3

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

200

453

4.63

81.81

1.4

1.3

—

Coronary atherosclerosis

1032

3336

1.98

81.76

1.8

1.4

—

Polyneuropathies and other disorders of the peripheral nervous system

456

1739

2.70

81.36

1.7

1.4

—

Acute bronchitis

820

3935

2.08

81.14

1.7

1.5

—

Non-ischemic cardiomyopathy

557

1810

2.49

81.02

1.8

1.4

—

Cardiomyopathy (excluding other)

287

846

3.52

80.87

1.7

1.4

—

Finngen Rheumatological endpoints

1857

6430

1.66

80.60

1.5

—

ILD-related respiratory insufficiency

125

188

7.25

80.56

1.5

1.3

—

Venous thromboembolism

918

4509

1.99

80.37

1.6

1.4

—

Cardiomyopathies, Primary/intrinsic

280

818

3.55

80.03

1.7

1.4

—

Idiopathic thrombocytopenic purpura

136

226

6.66

79.92

1.4

1.6

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

273

790

3.62

79.58

1.9

1.4

—

Other diseases of the digestive system

607

2663

2.33

79.55

1.7

1.4

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1369

7215

1.75

79.48

1.8

1.4

—

Other infectious diseases

215

529

4.28

79.13

2.0

1.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

158

306

5.63

78.76

2.8

1.5

—

Malignant neoplasm of liver and intrahepatic bile ducts

113

156

7.84

78.54

1.5

1.3

—

Parasetamol

1456

4198

1.77

78.50

1.5

1.4

—

6-mercaptopurine

159

313

5.54

77.80

1.3

1.5

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

133

220

6.41

77.66

1.5

1.3

—

Myelodysplastic syndrome

17.01

77.31

1.4

1.2

—

Disorders of mineral metabolism

234

623

3.93

77.12

2.0

1.4

—

Dermatitis and eczema

2114

7991

1.58

76.83

1.5

—

Complications of procedures, not elsewhere classified

1463

6969

1.71

76.59

1.8

1.4

—

Ulcerative colitis, NAS

382

1378

2.88

76.41

1.4

1.5

—

Other and unspecified polyneuropathies, also in other diseases

397

1458

2.80

76.34

1.8

1.4

—

Insulin, fast-acting (human)

380

1367

2.88

76.31

2.5

1.4

—

Mucosal proctocolitis

370

1315

2.93

76.21

1.3

1.5

—

Other infectious diseases, including avohilmo

245

680

3.77

76.00

1.9

1.4

—

Cardiac arrhythmias

1150

4025

1.86

75.75

1.6

1.4

—

GI-bleeding

595

2644

2.29

75.62

1.7

1.4

—

Nonalcoholic fatty liver disease

293

927

3.31

74.17

1.3

1.5

—

Hodgkin lymphoma, hilmo

135

241

6.23

73.89

1.4

—

Heart failure and bmi 25plus

594

1714

2.36

73.52

1.7

1.4

—

Other reaction to severe stress, and adjustment disorders

833

4256

2.00

73.37

1.7

1.4

—

Other diseases of pericardium

146

280

5.56

73.12

1.8

1.4

—

Amputation of toe

191

457

4.40

72.98

2.5

1.4

—

Other and unspecified dermatitis

1012

5526

1.86

72.63

1.6

1.4

—

ILD medications: pirfenidone

17.88

72.45

1.5

1.2

—

Acute sinusitis

1055

5283

1.84

72.40

1.6

1.4

—

Hepatocellular carcinoma

9.80

72.17

1.4

1.3

—

Valvular heart disease excluding rheumatic fever

794

2797

2.06

72.13

1.8

1.4

—

Pulmonary heart disease, diseases of pulmonary circulation

560

2475

2.31

72.12

1.6

1.4

—

Anxiety disorders, excluding more controls

1583

6142

1.67

71.85

1.5

—

Dermatitis

1176

6581

1.77

71.74

1.6

1.4

—

Non-rheumatic valve diseases

782

2744

2.06

71.63

1.8

1.4

—

Neurotic, stress-related and somatoform disorders

1730

7434

1.62

71.61

1.5

—

Abnormal results of function studies

261

787

3.48

71.46

1.5

—

Senile cataract

1014

3287

1.90

71.06

1.9

1.4

—

Anxiety disorders

1739

7469

1.61

70.86

1.5

—

Postviral fatigue syndrome

12.56

70.79

1.3

1.5

—

Other necrotizing vasculopathies (FG)

159

337

4.97

70.72

1.8

1.4

—

Hypo-osmolality and hyponatraemia

327

1123

2.96

69.94

1.9

1.3

—

Other noninfective gastroenteritis and colitis

545

2418

2.31

69.76

1.6

1.5

—

Toxic liver disease

10.31

69.74

1.6

1.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1013

5602

1.83

69.10

1.8

1.4

—

Disorders of choroid and retina

1360

5643

1.71

68.85

1.9

1.4

—

Other autoimmune haemolytic anaemias

12.20

68.28

1.5

1.3

—

Viral hepatitis, IBD co-morbidity

168

383

4.60

68.27

1.2

1.3

—

Other retinal disorders

1080

4589

1.81

68.16

2.0

1.4

—

Cardiomyopathy, other and unspecified

191

481

4.15

68.02

1.6

1.5

—

Other cataract

759

2812

2.04

67.68

2.0

1.4

—

Crohn disease

359

1338

2.79

67.57

1.4

1.5

—

Diseases of the eye and adnexa

1612

4940

1.65

67.54

1.6

1.4

—

Chronic tubulo-interstitial nephritis

116

193

6.41

67.46

2.3

1.2

—

Other soft tissue disorders, not elsewhere classified

1807

6514

1.59

67.39

1.5

—

IBD (strict) with PSC

10.95

67.38

1.4

—

Zoster [herpes zoster]

375

1426

2.70

67.35

1.6

1.4

—

Colitis, primary sclerosing, strict definition

10.39

66.87

1.5

1.4

—

Adjustment and management of implanted device

288

955

3.08

66.54

1.5

1.2

—

Marginal zone B-cell lymphoma, including Hilmo

10.97

66.47

1.5

1.4

—

ILD medications: nintedanib

29.22

66.22

1.4

1.2

—

Other and unspecified iron deficiency

628

3010

2.12

65.72

1.6

1.4

—

Depression medications

565

1219

2.37

65.66

1.4

1.2

—

Other systemic involvement of connective tissue (FG)

467

1951

2.40

65.52

1.2

1.4

—

Other CVD (FINNGEN)

217

442

3.85

65.27

1.7

1.2

—

Gout due to impairment of renal function

12.22

65.06

2.5

1.4

—

Hyperlipidaemia, other/unspecified

615

2622

2.14

65.04

1.8

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

417

1705

2.53

64.79

1.4

1.5

—

Osteoporosis

440

1678

2.46

64.40

1.7

1.3

—

Ulcerative colitis (strict definition, require KELA)

426

1764

2.49

64.37

1.4

1.5

—

Symptoms and signs concerning food and fluid intake

221

636

3.58

64.36

1.9

1.4

—

Diabetes, varying definitions

1847

6902

1.57

64.29

1.7

1.4

—

Ischaemic heart disease, wide definition

1216

4359

1.74

63.99

1.7

1.4

—

Other and unspecified aplastic anaemias

12.04

63.98

1.5

1.3

—

Disorders of calcium metabolism

174

433

4.22

63.13

2.0

1.4

—

Diabetes mellitus

1849

6921

1.56

62.75

1.7

1.4

—

Immunodeficiency with predominantly antibody defects

117

213

6.07

62.69

1.7

1.5

—

All influenza (not pneumonia)

339

1278

2.73

62.09

1.9

1.4

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

442

1891

2.41

62.06

1.4

1.5

—

Immunodeficiencies

164

399

4.40

61.80

1.7

1.5

—

Mature T/NK-cell lymphomas, hilmo

10.06

61.55

1.5

1.4

—

Pure hypercholesterolaemia

1158

4286

1.73

61.09

1.6

1.4

—

Asthma, hospital admissions 3, pneumonia

665

3341

2.02

60.90

1.6

1.5

—

Asthma-related pneumonia or sepsis

665

3341

2.02

60.90

1.6

1.5

—

Viral pneumonia (unknown virus, not influenza)

201

570

3.71

60.65

1.8

1.5

—

Peripheral artery disease

654

2551

2.05

60.62

2.1

1.3

—

Zoster [herpes zoster], including avohilmo

880

4689

1.84

60.59

1.5

1.4

—

Asthma-related pneumonia

663

3335

2.01

60.52

1.6

1.5

—

Presence of cardiac and vascular implants and grafts

617

2189

2.10

59.90

1.6

1.1

—

SLE (Finngen)

111

199

5.96

59.89

1.3

1.4

—

Cutaneous abscess, furuncle and carbuncle

581

2813

2.11

59.88

1.8

1.4

—

Asthma-related infections

1128

6544

1.70

59.80

1.5

—

Asthma, hospital admission 2, infections

1128

6544

1.70

59.80

1.5

—

Mycoses

574

2767

2.12

59.78

1.8

1.4

—

Diabetic retinopathy

665

2031

2.08

59.46

2.2

1.5

—

Paroxysmal tachycardia

403

1371

2.49

59.45

1.6

1.2

—

Diabetic maculopathy

312

1088

2.82

59.21

2.5

1.5

—

Pain (limb, back, neck, head abdominally)

1290

3861

1.69

59.10

1.5

—

Pain in throat and chest

1513

5633

1.61

58.80

1.5

1.4

—

Personal history of other diseases and conditions

305

1122

2.80

58.28

1.8

1.2

—

Other or ill-defined heart diseases

155

377

4.31

58.00

1.8

1.4

—

Diseases of the respiratory system

1077

3080

1.77

57.98

1.5

1.4

—

Depression

1772

7802

1.53

57.68

1.5

—

Diverticular disease of intestine

1102

4006

1.73

57.61

1.6

1.4

—

Osteomyelitis

180

495

3.82

56.87

2.3

1.5

—

Other diseases of arteries and capillaries

212

649

3.39

56.53

2.3

1.3

—

Cough

750

3754

1.89

56.45

1.6

1.4

—

Pericarditis

109

203

5.71

56.41

1.9

1.4

—

Other skin changes

383

1602

2.45

56.36

1.6

1.4

—

DVT of lower extremities and pulmonary embolism

667

3444

1.96

56.23

1.6

1.4

—

Respiratory insufficiency

152

370

4.22

56.19

1.7

1.3

—

Type 2 diabetes

1675

6304

1.55

56.16

1.7

1.4

—

Neurological diseases, wide definition

634

1536

2.11

56.13

1.5

1.4

—

Other systemic involvement of connective tissue

482

2225

2.21

56.06

1.2

1.4

—

Pulmonary embolism

488

2273

2.19

55.39

1.5

1.4

—

Mood disorders, excluding more controls

1664

6377

1.55

55.26

1.5

1.4

—

Statin medication

1221

4153

1.67

55.22

1.8

1.3

—

Arthropathies in other diseases classified elsewhere

120

249

5.15

55.12

2.4

1.4

—

Pulmonary heart disease

488

2278

2.18

55.09

1.5

1.4

—

Chronic gastritis

423

1864

2.31

55.00

1.5

1.4

—

Codeine or tramadol medication

1979

7262

1.49

54.68

1.4

—

Noninfectious colitis NAS

317

1238

2.64

54.25

1.5

—

Pain in joint

1047

3772

1.72

53.88

1.4

—

Myocarditis

123

265

4.85

53.60

1.4

1.2

—

Mood [affective] disorders

1843

7956

1.50

53.29

1.5

—

Mood disorders

1846

7959

1.50

53.23

1.5

—

Primary biliary cholangitis (PBC)

8.21

52.96

1.4

—

Other viral hepatitis, including avohilmo

209

665

3.31

52.75

1.4

1.5

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

11.71

52.72

2.1

1.3

—

Viral pneumonia (known virus, not influenza)

110

221

5.40

52.70

2.0

1.5

—

Early onset COPD, excluding more controls

318

1256

2.58

52.65

1.5

1.4

—

Haemorrhage, not elsewhere classified

100

183

5.74

52.59

1.9

1.3

—

892

5134

1.75

52.30

1.6

1.5

—

L01XE Protein kinase inhibitors

145

365

4.20

52.08

1.3

—

Viral hepatitis, including avohilmo

225

753

3.13

52.01

1.3

1.5

—

Endocarditis

108

215

5.33

51.93

1.8

1.4

—

Other gastritis (incl. Duodenitis)

388

1695

2.34

51.66

1.5

1.4

—

Haemorrhage from respiratory passages

573

2557

2.01

51.40

1.6

1.4

—

Dilated cardiomyopathy

252

901

2.89

51.36

1.6

1.5

—

Maternal care for known or suspected fetal abnormality and damage

385

1407

2.38

51.34

1.3

1.4

—

Symptoms and signs involving the urinary system

1270

6040

1.60

51.26

1.7

1.4

—

Pacemaker

538

2476

2.05

51.20

1.5

1.4

—

Charcot foot

119

7.35

51.13

2.7

1.3

—

Continuous positive airway pressure

325

1079

2.56

50.94

1.8

1.4

—

Other arthritis (FG)

559

2831

2.01

50.75

1.5

1.4

—

Presence of other functional implants

777

2932

1.83

50.46

1.7

1.1

—

Other diseases of the respiratory system

350

1478

2.42

50.39

1.7

1.4

—

Other respiratory disorders and diseases

350

1478

2.42

50.39

1.7

1.4

—

Systemic lupus erythematosus

111

233

5.08

50.28

1.3

1.4

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1558

6074

1.53

50.07

1.8

1.4

—

Persons encountering health services for specific procedures, not carried out

212

699

3.14

50.01

1.5

1.2

—

Cerebral cysts

173

507

3.59

49.79

1.5

—

Molar incisor enamel hypoplasia

178

513

3.60

49.13

3.8

1.6

—

Persons encountering health services in other circumstances

753

4194

1.80

49.01

1.6

1.4

—

Cardiac arrest

134

270

4.35

48.99

2.0

1.3

—

Other metabolic disorders

283

1099

2.65

48.97

1.6

1.4

—

L01XX Other antineoplastic agents

139

354

4.11

48.97

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

703

2521

1.88

48.97

1.5

1.3

—

Other Crohn's disease

203

663

3.21

48.96

1.3

1.5

—

Other pleural conditions

200

645

3.20

48.86

1.5

1.4

—

Pain in limb

1513

6339

1.53

48.65

1.6

1.5

—

Other viral hepatitis

192

612

3.30

48.35

1.4

1.5

—

Isolated proteinuria

110

239

5.00

48.14

2.5

1.4

—

Persons with potential health hazards related to communicable diseases

847

4920

1.74

48.10

1.8

1.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1573

6634

1.51

47.67

1.6

1.4

—

STROKE

816

3125

1.78

47.66

1.6

1.3

—

Congenital malformations of gallbladder, bile ducts and liver

8.46

47.45

3.0

1.7

—

Viral warts

257

970

2.75

47.38

2.4

1.4

—

Hypoplasia of dental enamel , including avohilmo

169

486

3.63

47.35

3.8

1.7

—

Viral hepatitis

206

692

3.11

47.34

1.3

1.5

—

Biological medication for rheuma

424

2003

2.17

46.96

1.3

1.5

—

Other diseases of intestine

289

1156

2.56

46.95

1.7

1.5

—

Other and unspecified diseases of blood and blood-forming organs

164

5.85

46.83

1.3

1.4

—

Disorders of sclera, cornea, iris and ciliary body

975

5968

1.65

46.78

1.6

1.4

—

Viral and other specified intestinal infections, including avohilmo

642

3362

1.87

46.77

2.0

1.4

—

Anxiety (asthma-related co-morbidities)

1185

5731

1.59

46.32

1.5

—

Unspecified nephritic syndrome

153

6.06

46.02

2.9

1.3

—

Amputation of ankle bones

126

6.61

45.81

2.6

1.3

—

Abnormal findings on diagnostic imaging of other body structures

280

1118

2.57

45.76

1.5

1.4

—

Hepatomegaly and splenomegaly, not elsewhere classified

10.21

45.71

1.9

1.5

—

Hydronephrosis

212

734

2.97

45.71

2.2

1.2

—

Diagnoses used for exclusion with ILD

429

2055

2.13

45.48

1.5

1.4

—

Abnormal findings on examination of urine, without diagnosis

133

348

4.05

45.38

2.4

1.4

—

Diseases of spleen

128

6.64

45.34

1.6

1.4

—

SLE, ICD10

104

226

4.91

45.25

1.3

1.4

—

SLE, strict definition

104

226

4.91

45.25

1.3

1.4

—

Ulcerative colitis (strict) with PSC

9.89

45.18

1.4

1.5

—

Chronic periodontitis, including avohilmo

1637

7110

1.48

45.10

1.7

1.4

—

Periodontitis

1639

7113

1.48

45.07

1.7

1.4

—

Convulsions, not elsewhere classified

393

1804

2.19

44.85

1.6

1.4

—

All anxiety disorders

1214

6084

1.57

44.64

1.5

—

Chronic apical periodontitis

1923

7550

1.44

44.60

1.5

1.4

—

Chronic periodontitis, complicated

916

5439

1.66

44.54

1.7

1.4

—

Pleural effusion

260

1015

2.62

44.43

1.5

1.4

—

Other specified/unspecified arthritis

497

2541

1.99

44.04

1.5

1.4

—

Other obstetric conditions, not elsewhere classified

695

2432

1.83

44.04

1.3

1.4

—

Nonischemic cardiomyopathy

203

701

2.98

44.03

1.8

1.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

562

2315

1.93

44.01

2.0

1.3

—

Any operation in hilmo

11.24

43.97

1.3

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

684

2388

1.84

43.41

1.3

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

1635

6658

1.47

43.30

1.8

1.4

—

Myocardial infarction

679

2640

1.82

43.16

1.6

1.4

—

Volume depletion

184

608

3.11

43.13

2.2

1.4

—

Other disorders of lacrimal gland

617

3409

1.84

42.98

1.6

1.4

—

Chronic myeloid leukaemia, including Hilmo

11.21

42.83

1.1

—

Gingivitis and periodontal diseases

1609

5649

1.48

42.81

1.6

1.4

—

Other diseases of blood and blood-forming organs

156

473

3.43

42.43

1.4

1.5

—

Undetermined asthma, excluding more controls

228

852

2.73

42.43

1.5

1.3

—

Neurological diseases

1580

5384

1.49

42.24

1.4

1.5

—

Viral and other specified intestinal infections

495

2504

1.97

42.13

2.2

1.4

—

Hypertensive Heart Disease

328

1077

2.34

42.03

2.1

1.2

—

Sequelae of external causes of morbidity and mortality

460

2329

2.01

42.00

1.9

1.4

—

Sequelae with surgical and medical care as external cause

364

1690

2.20

42.00

1.9

1.4

—

Major coronary heart disease event excluding revascularizations

815

3170

1.71

41.91

1.6

1.4

—

Cellulitis

440

2202

2.04

41.60

1.9

1.5

—

Gastro-oesophageal reflux disease

1093

5925

1.57

41.54

1.6

1.4

—

Gastroduodenal ulcer

382

1808

2.14

41.38

1.7

1.4

—

Urinary track infection

1028

3191

1.63

41.23

1.5

1.3

—

Acute pancreatitis

341

1554

2.24

41.19

1.6

1.4

—

Cholelithiasis, broad definition with cholecystitis

1330

5899

1.51

41.05

1.5

1.4

—

Phlebitis and thrombophlebitis (not including DVT)

391

1882

2.12

41.05

1.8

1.4

—

Diabetes medication

1759

7199

1.44

41.01

1.7

1.4

—

Other disorders of urethra and urinary system

1157

5231

1.55

40.54

1.7

1.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

273

1140

2.45

40.46

2.0

1.4

—

Undetermined asthma

228

875

2.66

40.28

1.5

1.3

—

Other ulcerative colitis

159

506

3.29

40.15

1.4

1.5

—

Diseases of the musculoskeletal system and connective tissue

1055

3324

1.61

40.05

1.5

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

327

1491

2.25

39.72

1.3

1.5

—

Herpesviral [herpes simplex] infections

253

1033

2.52

39.61

1.6

1.4

—

Amputation of foot

156

5.48

39.55

2.8

1.4

—

Osteonecrosis

145

440

3.43

39.46

1.7

1.4

—

Diaphragmatic hernia

532

2887

1.87

39.29

1.4

—

Unspecified haematuria

662

3097

1.76

38.99

1.8

1.4

—

Hypothyroidism, drug reimbursement

222

572

2.76

38.79

1.6

1.2

—

Hypokalaemia

215

821

2.68

38.54

1.7

1.3

—

Candidiasis, including avohilmo

571

3190

1.82

38.51

1.6

1.4

—

Visual disturbances and blindness

873

5453

1.62

38.50

1.5

—

Candidiasis

294

1306

2.31

37.99

1.8

1.4

—

Other acute viral hepatitis

120

6.40

37.99

1.1

1.5

—

Other embolism and thrombosis

234

939

2.55

37.92

1.7

1.4

—

Infectious mononucleosis, including avohilmo

242

991

2.53

37.90

1.3

1.4

—

Infectious mononucleosis

242

991

2.53

37.90

1.3

1.4

—

Crohn's disease NAS

173

598

3.02

37.86

1.4

1.5

—

Secondary thrombocytopenia

8.00

37.66

1.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

242

990

2.51

37.66

1.5

1.3

—

Peripheral arterial reconstruction

249

1034

2.45

37.34

2.2

1.3

—

Systemic lupus erythematosus, unspecified

205

4.68

37.04

1.3

1.4

—

Idiopathic gout

175

614

2.93

37.02

2.1

1.4

—

Other renal tubulo-interstitial diseases

143

5.51

36.93

2.4

1.3

—

Myeloproliferative diseases

163

551

3.06

36.93

1.3

—

Other diseases of urinary system

1654

6552

1.43

36.89

1.7

1.4

—

Exposure to unspecified factor

1763

8614

1.40

36.76

1.5

—

Abnormalities of heart beat

583

3214

1.78

36.71

1.4

—

Diseases of oral cavity, salivary glands and jaws

794

2450

1.68

36.51

1.5

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

796

3833

1.64

36.32

1.7

1.4

—

Soft tissue disorders

1799

6597

1.41

36.29

1.5

—

Acute pancreatitis (for exclusion)

341

1636

2.12

36.21

1.6

1.4

—

Crohn disease (strict definition, require KELA, min 2 HDR)

176

630

2.91

36.19

1.3

1.5

—

Arthropathies

1652

5892

1.43

36.10

1.4

1.5

—

Crohn disease (strict definition, require KELA)

177

637

2.90

36.03

1.3

1.5

—

Localized swelling, mass and lump of skin and subcutaneous tissue

545

3063

1.81

36.01

1.5

1.4

—

Invasive ventilation

165

571

3.00

35.95

2.1

1.5

—

Coxarthrosis [arthrosis of hip](FG)

757

3146

1.67

35.94

1.3

1.4

—

Other CVD

293

1330

2.24

35.71

1.7

1.4

—

Cholelithiasis

1246

5764

1.49

35.66

1.4

—

Disorders of lacrimal system

702

4168

1.68

35.63

1.5

1.4

—

Tumor necrosis factor alpha inhibitors

362

1791

2.07

35.60

1.3

1.5

—

Thrombotic microangiopathy

11.11

35.55

1.5

1.4

—

Collagenous colitis

191

718

2.74

35.53

1.4

—

Sarcoidosis

251

1073

2.40

35.52

1.5

1.4

—

Malignant neoplasm of skin, including Hilmo

661

2583

1.73

35.47

1.6

1.5

—

Other functional intestinal disorders

731

4043

1.66

35.38

1.6

1.5

—

COPD-related respiratory insufficiency

196

748

2.68

35.24

1.8

1.4

—

Crohn's disease of large intestine

143

464

3.23

35.05

1.4

1.5

—

Disorders of vitreous body and globe

749

4366

1.64

34.73

1.8

1.4

—

Benign neoplasm: Colon

766

4456

1.63

34.66

1.6

1.4

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

122

5.80

34.64

2.2

1.3

—

COPD (mode)

371

1428

2.05

34.59

1.5

1.4

—

Heart failure and hypertrophic cardiomyopathy

112

6.09

34.56

1.5

1.4

—

Other diseases of hard tissues of teeth

779

2442

1.67

34.54

1.6

1.3

—

Cystic disease of liver

10.85

34.50

1.8

1.3

—

Other problems related to primary support group, including family circumstances

295

1329

2.22

34.49

2.7

1.4

—

Malignant neoplasm of digestive organs, including Hilmo

530

2162

1.82

34.45

1.4

1.5

—

Procreative management

667

3293

1.69

33.98

1.6

—

Chronic hepatitis NAS

6.74

33.95

1.4

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

191

735

2.68

33.94

1.6

1.4

—

Marginal zone B-cell lymphoma

10.52

33.86

1.3

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

181

681

2.76

33.83

1.3

1.5

—

Other anxiety disorders

911

5021

1.56

33.79

1.4

—

Unspecified acute lower respiratory infection

304

1439

2.16

33.57

1.9

1.5

—

Other nutritional deficiencies

1183

7412

1.47

33.51

1.5

—

Pre-eclampsia or poor fetal growth

557

3207

1.76

33.42

1.5

1.3

—

Acute lymphocytic leukaemia

7.17

33.38

1.5

1.9

—

Acute lymphocytic leukaemia, including Hilmo

7.17

33.38

1.5

1.9

—

Acute lymphocytic leukaemia, helper endpoint

7.17

33.38

1.5

1.9

—

Melanocytic naevi

571

3328

1.74

33.34

1.9

1.4

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

252

1109

2.32

33.29

2.0

1.4

—

Urticaria and erythema

667

4055

1.67

33.16

1.6

1.5

—

Chronic pancreatitis

227

958

2.43

33.08

1.7

1.5

—

Seborrhoeic keratosis

371

1896

1.99

33.04

1.6

1.4

—

Benign neoplasm of colon, rectum, anus and anal canal

894

4894

1.56

33.03

1.6

1.4

—

Iridocyclitis

401

2107

1.94

33.01

1.6

1.4

—

Disorders of thyroid, IBD co-morbidities

307

977

2.18

32.63

1.5

1.3

—

Isolated proteinuria with specified morphological lesion

6.88

32.61

3.1

1.3

—

Cystitis

1359

5644

1.44

32.58

1.5

1.4

—

Other maternal disorders predominantly related to pregnancy

893

3588

1.57

32.58

1.4

—

Disorders of vitreous body

724

4280

1.63

32.56

1.8

1.4

—

Maternal care for other known or suspected fetal problems

486

1667

1.86

32.38

1.4

—

Visual disturbances

795

5076

1.58

32.22

1.5

—

Diabetic neuropathy

232

1002

2.37

31.86

2.2

1.6

—

Myocardial infarction, strict

595

2471

1.72

31.76

1.6

1.4

—

Other general symptoms and signs

115

343

3.43

31.61

1.5

—

Any mental disorder

1767

6465

1.38

31.54

1.5

—

Episodal and paroxysmal disorders

1863

6966

1.37

31.52

1.4

1.5

—

Dysphagia

365

1886

1.96

31.47

1.5

1.4

—

Chronic myeloproliferative disease

7.27

31.14

1.4

1.5

—

Benign neoplasms

1714

6817

1.38

31.08

1.6

1.4

—

Nonhereditary hypogammaglobulinemia

7.18

30.98

1.4

—

Acute nephritic syndrome

163

4.82

30.97

2.5

1.4

—

Hypoplasia of dental enamel, prenatal

16.73

30.96

6.7

2.4

—

Herpesviral [herpes simplex] infections, including avohilmo

483

2744

1.79

30.94

1.5

1.4

—

Other and unspecified acquired haemolytic anaemias

7.89

30.83

1.7

1.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

147

511

2.89

30.79

1.6

1.3

—

Secondary right heart disease

249

3.89

30.68

1.6

1.3

—

Eosinophilic disease (BM)

6.51

30.66

1.3

—

Other and unspecified coagulation defects

127

416

3.18

30.64

1.5

1.4

—

Acquired absence of organs, not elsewhere classified

7.66

30.62

2.6

1.1

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

8.41

30.41

1.5

1.3

—

Hypothyroidism, strict autoimmune

1072

4774

1.48

30.40

1.5

1.3

—

Hypotension

245

1106

2.25

30.37

1.6

1.3

—

Non-allergic asthma (mode), excluding more controls

270

1258

2.16

30.13

1.6

1.3

—

Chorioretinal inflammation

213

4.17

30.08

1.3

1.4

—

Gastric ulcer

253

1162

2.21

30.06

1.7

1.4

—

Other diseases of pancreas

158

588

2.76

30.03

1.7

1.4

—

Viral warts, including avohilmo

438

2442

1.83

29.98

2.0

1.4

—

Pruritus

223

977

2.34

29.89

1.7

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

558

2203

1.72

29.79

1.6

1.5

—

Caries of enamel

1630

7828

1.37

29.77

1.6

1.4

—

Other coagulation defects

160

603

2.74

29.74

1.5

1.4

—

Need for other prophylactic measures

140

493

2.95

29.72

1.8

1.5

—

Disorders of skin appendages

904

6023

1.51

29.43

1.6

1.4

—

Chronic ulcer of skin, not elsewhere classified

129

435

3.05

29.42

2.6

1.3

—

Hypersplenism

13.41

29.32

1.7

1.3

—

Other and unspecified drugs and medicaments

177

706

2.58

29.32

1.6

1.4

—

Hypocalcemia

183

4.44

29.27

2.2

1.4

—

Malignant neoplasm of digestive organs

465

2000

1.79

29.23

1.4

1.5

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

11.87

29.16

1.6

1.1

—

Acute pharyngitis

343

1768

1.96

29.15

1.6

1.5

—

Other and unspecified local infections of skin and subcutaneous tissue

201

852

2.42

29.14

1.9

1.5

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

570

3405

1.68

29.13

2.1

1.4

—

Other abnormalities of plasma proteins

6.15

28.98

1.6

1.4

—

Coxarthrosis

698

2814

1.61

28.79

1.3

1.4

—

Other pulmonary heart/vessel disease

290

3.55

28.59

1.6

1.4

—

Malignant neoplasm of skin

591

2405

1.68

28.58

1.6

1.5

—

Crohn's disease of small intestine

164

640

2.65

28.51

1.3

1.5

—

Disorders of tooth development and eruption

302

1216

2.05

28.50

1.6

1.3

—

Non-allergic asthma (mode)

270

1288

2.11

28.37

1.6

1.4

—

Dental operations

820

2715

1.56

28.35

1.5

1.3

—

Nonorganic sleeping disorders, excluding more controls

394

2165

1.85

28.27

1.5

1.4

—

Amiodarone users

175

706

2.54

28.26

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

180

739

2.51

28.06

2.0

1.5

—

Low back pain

1315

6365

1.40

27.92

1.4

1.5

—

Asthma (diagnoses ohter than nonallergic)

1448

8564

1.37

27.81

1.4

1.5

—

Disorders of oesophagus in diseases classified elsewhere

117

5.25

27.62

1.7

1.4

—

Kela reimbursement Agammaglobulinemia (D80-84)

7.10

27.27

1.9

1.4

—

Ulcerative ileocolitis

105

330

3.33

27.25

1.4

1.5

—

Vocal cord dysfunction

211

817

2.31

27.18

1.5

1.3

—

Constipation

1376

6770

1.39

27.07

1.5

—

Migraine

932

4935

1.48

27.06

1.4

1.5

—

Hypercalcemia

287

3.48

26.92

2.0

1.4

—

Other specified/unspecified systemic involvement of connective tissue

117

394

3.07

26.87

1.4

1.3

—

Paralytic ileus and intestinal obstruction

357

1934

1.87

26.64

1.4

—

Missing teeth due to accident, extraction or parodontitis

891

5405

1.48

26.60

1.6

1.4

—

Neovascular glaucoma

266

3.56

26.41

2.1

1.4

—

Other local infections of skin and subcutaneous tissue

205

915

2.30

26.41

1.9

1.5

—

Tubulo-interstitial nephritis, not specified as acute or chronic

117

397

3.02

26.39

2.1

1.2

—

Other arrhythmias

942

4817

1.47

26.20

1.5

1.4

—

Special screening examination for infectious and parasitic diseases

434

1801

1.78

26.17

1.3

—

Osteopathy in diseases classified elsewhere

8.21

26.10

2.0

1.6

—

Glaucoma secondary to other eye disorders

269

3.52

25.96

2.1

1.4

—

Other diseases of anus and rectum

437

2527

1.74

25.90

1.5

1.4

—

Other specific joint derangements/joint disorders

1274

5736

1.39

25.58

1.5

—

Microscopic polyangiitis

9.71

25.56

2.2

1.6

—

Squamous cell neoplasms and carcinomas of the skin

118

410

2.92

25.37

1.5

1.3

—

Malignant neoplasm of urinary organs, including Hilmo

153

609

2.56

25.33

1.8

1.5

—

Use of hypnotics and sedatives

1668

7180

1.34

25.19

1.5

—

Diseases of pulp and periapical tissues, including avohilmo

1696

6605

1.34

25.17

1.4

1.5

—

Obesity

1073

7191

1.42

25.12

1.5

1.4

—

Intestinal stricture

436

2554

1.73

25.07

1.5

1.4

—

Diabetes mellitus in pregnancy

578

2271

1.64

25.05

1.5

1.4

—

Cholecystectomy

1004

5985

1.43

25.00

1.4

—

Other complications of surgical and medical care, not elsewhere classified

180

779

2.37

24.93

1.5

1.3

—

Elevated blood glucose level

162

670

2.48

24.88

1.9

1.5

—

Shock, not elsewhere classified

9.27

24.86

2.4

1.3

—

Obesity and other hyperalimentation

1075

7213

1.41

24.78

1.5

1.4

—

Other congenital malformations of the digestive system

134

508

2.74

24.59

2.8

1.8

—

Diseases of pulp and periapical tissues and dental caries

931

3259

1.47

24.57

1.5

1.4

—

Subjective visual disturbances

419

2444

1.74

24.57

1.4

—

Injuries to the ankle and foot

1272

7966

1.37

24.55

1.6

1.5

—

Hernia

1427

7038

1.35

24.44

1.6

1.5

—

Malignant immunoproliferative diseases

6.66

24.30

2.0

1.5

—

Dermatitis due to substances taken internally

123

451

2.82

24.25

1.7

1.4

—

Other/unspecified dorsalgia

596

3770

1.58

23.94

1.5

—

Anterior Iridocyclitis

338

1868

1.84

23.92

1.6

1.4

—

Angina pectoris

679

2927

1.55

23.89

1.6

1.4

—

Fentanyl

144

572

2.56

23.85

1.5

1.4

—

Coxarthrosis, primary, with hip surgery

576

3390

1.59

23.80

1.2

1.4

—

Functional dyspepsia

408

2386

1.73

23.67

1.5

1.4

—

Calcific aortic valvular stenosis, operated

348

1866

1.81

23.67

1.6

1.4

—

Calcific aortic valvular stenosis

348

1866

1.81

23.67

1.6

1.4

—

Calcific aortic valvular stenosis, including rheumatic fever

347

1857

1.82

23.66

1.6

1.4

—

Obesity related asthma

548

3456

1.60

23.66

1.5

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

507

2092

1.66

23.63

1.6

1.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

346

1853

1.82

23.63

1.6

1.4

—

Operations 2 for CAVS

346

1853

1.82

23.63

1.6

1.4

—

Adalimumab

221

1066

2.13

23.55

1.3

1.5

—

Other arterial embolism and thrombosis

146

4.35

23.52

2.6

1.4

—

Type 2 diabetes, definitions combined

1372

5908

1.36

23.41

1.5

1.4

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

136

532

2.61

23.40

1.9

1.5

—

Other symptoms and signs involving the digestive system and abdomen

248

1249

2.01

23.23

1.7

1.4

—

Benign neoplasm of other and ill-defined parts of digestive system

260

1335

1.98

23.10

1.5

1.4

—

Amyloidosis

132

4.54

23.01

1.7

1.4

—

Sleep apnoea

1418

6684

1.34

22.96

1.4

1.5

—

Poor fetal growth

272

1427

1.95

22.86

1.4

1.3

—

Acute and subacute iridocyclitis

318

1751

1.85

22.81

1.7

1.4

—

Other and unspecified immunodeficiencies with predominantly antibody defects

5.35

22.80

2.1

1.5

—

Drug-induced adrenocortical insufficiency

134

4.54

22.70

1.6

—

Other specified disorders of kidney and ureter

214

3.66

22.69

2.5

1.3

—

Type 2 diabetes, strict (exclude DM1)

1378

5978

1.35

22.43

1.5

1.4

—

Other or unspecified ileus, impaction or obstruction

248

1265

1.99

22.37

1.4

—

Liver disorders in diseases classified elsewhere

21.80

22.37

1.3

—

Other congenital malformations of the digestive system, including avohilmo

141

574

2.54

22.29

2.7

1.8

—

479

2656

1.64

22.28

1.6

1.3

—

Generalized skin eruption due to drugs and medicaments

318

3.11

22.23

1.8

1.5

—

Other disorders of adrenal gland

105

372

2.93

22.17

1.6

1.5

—

Other antidepressants

1636

6373

1.32

22.15

1.4

1.5

—

Hernia of abdominal wall

677

4540

1.51

22.10

1.8

1.4

—

Malignant neoplasm of urinary organs

132

524

2.57

22.07

1.9

1.4

—

Abnormality of white blood cells, not elsewhere classified

6.69

22.06

1.6

1.4

—

Dorsalgia

1630

6599

1.32

22.04

1.4

1.5

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.27

22.03

5.5

2.1

—

Other and unspecified tonsillitis

659

3639

1.52

21.97

1.7

1.4

—

Adrenocortical insufficiency

259

3.34

21.83

1.6

1.5

—

Arterial embolism and thrombosis

309

3.08

21.82

2.2

1.3

—

Myocardial infarction, without ST-elevation

491

2763

1.62

21.81

1.6

1.4

—

Spondylopathies in diseases classified elsewhere

6.63

21.77

1.6

—

Acute generalized exanthematous pustulosis

101

355

2.95

21.64

1.7

1.5

—

Diseases of middle ear and mastoid

1021

6023

1.40

21.62

1.6

1.4

—

Use of pramipexole

305

1685

1.83

21.62

1.9

1.4

—

Background retinopathy and retinal vascular changes

139

4.33

21.58

2.0

1.4

—

Disorder of lipoprotein metabolism, unspecified

179

821

2.22

21.55

1.6

1.3

—

Eosinophilia

123

4.62

21.51

1.5

1.4

—

Melanocytic naevi of trunk

229

1158

2.02

21.41

2.0

1.4

—

Basal cell carcinoma, including Hilmo

502

2115

1.62

21.40

1.6

1.4

—

Covid-19 suspected case

388

2305

1.71

21.39

1.6

1.4

—

Crohn disease (strict definition, all UC cases excluded)

123

483

2.64

21.29

1.2

1.5

—

Rare circulating lymphoid malignancy

19.54

21.25

1.2

1.4

—

Asthma, hospital admissions , main diagnosis only

1314

8614

1.33

21.25

1.5

—

Actinic keratosis

429

2370

1.66

21.24

1.6

1.3

—

Urticaria

524

3360

1.58

21.15

1.6

1.5

—

Type 2 diabetes, definitions combined, including avohilmo

1378

6000

1.33

20.99

1.5

1.4

—

Wegener granulomatosis

105

4.90

20.94

1.9

1.4

—

Renal agenesis and other reduction defects of kidney, including avohilmo

7.21

20.93

2.1

1.5

—

Recurrent aphthous stomatitis , including avohilmo

261

1390

1.91

20.91

1.6

1.5

—

Obesity due to excess calories

803

5628

1.44

20.91

1.5

—

Lichen simplex chronicus and prurigo

118

459

2.64

20.73

1.8

1.4

—

Osteonecrosis due to drugs

5.03

20.71

1.7

1.3

—

Cerebrovascular diseases

970

4830

1.40

20.68

1.6

1.4

—

Dental caries, including avohilmo

1025

3769

1.40

20.63

1.5

1.4

—

External causes of morbidity and mortality

1074

3898

1.39

20.53

1.5

1.4

—

Other neurological diseases

994

5583

1.39

20.49

1.5

1.4

—

Cardiodefibrillation

450

2800

1.62

20.35

1.5

1.4

—

Other obstructive and reflux uropathy

302

3.04

20.28

2.3

1.3

—

Skin changes due to chronic exposure to nonionizing radiation

439

2459

1.63

20.20

1.6

1.3

—

Malignant neoplasm of kidney, except renal pelvis

122

489

2.54

20.05

2.0

1.5

—

Renal agenesis and other reduction defects of kidney

7.42

20.04

2.1

1.5

—

Cholecystitis

190

919

2.10

19.98

1.5

1.4

—

Disorders of eyelid, lacrimal system and orbit

1299

7202

1.33

19.97

1.5

1.4

—

Amyloidosis, other/unspecified

113

4.58

19.95

1.8

1.4

—

Myalgia

395

2401

1.67

19.94

1.4

—

Nerve, nerve root and plexus disorders

1617

7537

1.29

19.94

1.5

1.4

—

Caries of dentine, including avohilmo

1148

4320

1.37

19.90

1.5

1.4

—

Ulcerative rectosigmoiditis

158

715

2.26

19.85

1.4

1.5

—

Decubitus ulcer and pressure area

101

371

2.79

19.83

2.3

1.3

—

Fibromyalgia

166

766

2.21

19.82

1.2

1.3

—

Keratitis

563

3721

1.53

19.81

1.6

1.4

—

Aspergillosis

6.31

19.75

2.1

1.4

—

Aspergillosis, including avohilmo

6.29

19.73

2.1

1.4

—

Acute lymphadenitis

128

531

2.48

19.72

1.5

—

Acute posthaemorrhagic anaemia

185

3.63

19.69

1.8

1.3

—

Other congenital malformations of urinary system

6.39

19.61

4.6

1.6

—

Misadventures to patients during surgical and medical care

221

1138

1.97

19.58

2.0

1.3

—

Encephalopathy

5.83

19.42

1.2

1.4

—

Retinal detachments and breaks

457

2896

1.59

19.40

1.7

1.3

—

Other mycoses, not elsewhere classified/unspecified

9.51

19.38

1.9

1.2

—

Irregular menses

789

4167

1.43

19.36

1.4

—

AV-block

221

965

1.98

19.34

1.7

1.4

—

Mycoses, including avohilmo

1484

8752

1.30

19.32

1.5

—

Alcohol use disorder, Swedish definition

844

5488

1.41

19.27

1.4

1.5

—

Coxarthrosis, primary

728

4200

1.45

19.26

1.3

1.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

269

1435

1.84

19.20

1.2

1.5

—

Psychiatric diseases

1518

5860

1.30

19.15

1.5

—

Stomatitis and related lesions

347

2066

1.70

19.06

1.6

1.5

—

Postpartum care and examination

259

867

1.91

18.93

1.4

—

Chronic myeloid leukaemia

16.85

18.90

1.1

—

Portal vein thrombosis

110

4.54

18.84

1.8

1.5

—

Unspecified privation

188

930

2.06

18.76

1.7

1.4

—

Umbilical hernia

430

2714

1.60

18.68

1.8

1.5

—

Systemic sclerosis (FG)

128

4.16

18.56

1.4

1.5

—

Benign neoplasm: Colon, unspecified

327

1929

1.71

18.52

1.6

1.4

—

Other diseases of stomach and duodenum

104

403

2.64

18.42

1.9

1.4

—

Chronic lower respiratory diseases

1944

8186

1.26

18.39

1.5

—

DVT of lower extremities

252

1382

1.85

18.38

1.7

1.4

—

Hypertrophic cardiomyopathy

309

2.92

18.36

1.6

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

859

6228

1.39

18.35

1.5

—

Depression or dysthymia

1027

4122

1.37

18.32

1.5

—

Irritable bowel syndrome

424

2679

1.60

18.31

1.4

—

Disorders of conjunctiva

1362

8149

1.30

18.27

1.5

—

Childhood asthma (age<16), excluding more controls

282

1239

1.81

18.22

1.5

1.3

—

Disease of hard tissues of teeth, NOS

675

2409

1.48

18.19

1.4

1.3

—

Hypoglycaemia, other or unspecified

137

607

2.32

18.18

2.0

1.5

—

Dorsopathies

1681

6702

1.28

18.03

1.4

1.5

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

681

4122

1.44

17.83

1.5

1.3

—

Habitual aborter

199

3.44

17.80

1.6

1.4

—

899

5889

1.37

17.64

1.4

1.5

—

Nonorganic sleeping disorders

394

2474

1.61

17.58

1.5

1.4

—

Outcome of delivery

285

985

1.80

17.50

1.3

1.4

—

939

6037

1.36

17.48

1.4

1.5

—

Childhood asthma (age<16)

283

1262

1.78

17.43

1.5

1.3

—

Special screening examination for other diseases and disorders

182

912

2.02

17.42

1.9

1.4

—

Erosion of teeth , including avohilmo

489

3230

1.53

17.41

2.1

1.4

—

Unspecified contracted kidney

7.94

17.33

2.5

1.3

—

Fall on same level

1868

7985

1.25

17.33

1.5

—

Pregnancy hypertension

626

3870

1.46

17.32

1.5

1.3

—

Other joint disorders

1444

5854

1.29

17.27

1.4

1.5

—

Viral infections of the central nervous system, including avohilmo

142

654

2.22

17.16

1.3

1.4

—

Ulcerative enterocolitis

250

3.08

17.14

1.3

1.5

—

Acquired absence of limb

6.04

17.08

3.3

1.2

—

Other dorsopathies, not elsewhere classified

1616

6628

1.27

17.04

1.4

1.5

—

Inflammatory diseases of the central nervous system

151

717

2.15

16.89

1.4

1.5

—

Recurrent or chronic depression

663

3208

1.45

16.87

1.4

1.5

—

Early onset COPD

318

1912

1.68

16.87

1.5

—

Weight loss

170

844

2.05

16.85

1.6

1.4

—

In situ neoplasms

527

3558

1.49

16.79

1.5

1.3

—

Lower back pain or/and sciatica

1670

8274

1.26

16.77

1.4

—

Other leukaemias of specified cell type

22.58

16.72

1.5

1.4

—

Acute suppurative otitis media

541

3425

1.49

16.67

1.8

1.4

—

Medullary cystic kidney disease, nephronophthisis

30.57

16.67

2.9

1.3

—

Sleep apnoea, including avohilmo

1478

7023

1.28

16.66

1.4

1.5

—

Disorders of the thyroid gland

1439

7323

1.28

16.64

1.5

1.4

—

Adult respiratory distress syndrome

5.10

16.63

2.1

1.5

—

Fluid overload

14.81

16.63

2.7

1.2

—

Carcinoma in situ of skin

118

509

2.36

16.62

1.9

1.3

—

L04AC Interleukin inhibitors

138

639

2.22

16.53

1.3

1.5

—

Suppurative and unspecified otitis media

681

4276

1.42

16.52

1.7

1.4

—

Systemic sclerosis

140

3.79

16.42

1.4

1.5

—

Polyarteritis nodosa and related conditions

105

4.36

16.39

1.4

1.5

—

Giant cell arteritis

224

3.12

16.37

1.1

1.3

—

Congenital malformation of biliary tract

7.30

16.36

4.5

1.9

—

Dermatopolymyositis (FG)

4.79

16.36

1.4

1.3

—

Cardiomyopathy, Hypertrophic obstructive

109

4.23

16.36

1.8

1.4

—

Unknown and unspecified causes of morbidity

385

2.56

16.36

1.8

1.4

—

Cytomegaloviral hepatitis

15.73

16.34

1.3

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

507

3420

1.50

16.29

1.5

—

Carcinoma in situ of skin of scalp and neck

136

3.81

16.28

1.8

1.3

—

Disturbances of skin sensation

443

2909

1.54

16.22

1.3

1.4

—

Spondyloarthritis

273

1594

1.73

16.16

1.5

1.4

—

Other abnormal products of conception

544

2416

1.49

16.10

1.4

—

Fibrosis of liver

5.79

16.01

2.0

1.3

—

Sleep disorders (combined)

1714

7174

1.25

15.99

1.4

1.5

—

Hyphaema and other vascular disorders of iris and ciliary body

143

3.73

15.97

1.8

1.4

—

Other specified/unspecified bacterial intestinal infections

113

488

2.37

15.95

1.4

—

Special screening examination for neoplasms

100

408

2.50

15.95

1.4

1.3

—

Total colectomy

351

2.65

15.92

1.4

1.5

—

Total colectomy operation

351

2.65

15.92

1.4

1.5

—

Explicit fungal Sepsis

6.56

15.92

1.6

1.3

—

Other specified/unspecified necrotizing vasculopathies

4.78

15.89

2.4

1.5

—

Discitis, unspecified

4.54

15.88

1.6

1.5

—

Viral infections of the central nervous system

130

597

2.23

15.87

1.4

—

Myeloproliferative diseases (CML excluded)

115

502

2.34

15.82

1.3

—

Melanocytic naevi, other sites/unspecified

156

770

2.07

15.79

2.2

1.4

—

Primary coxarthrosis, bilateral

331

2044

1.63

15.78

1.3

1.4

—

Benzodiazepine use

1542

8294

1.26

15.77

1.4

1.5

—

Infliximab

215

3.18

15.74

1.2

1.5

—

Conjunctivitis (acute, non atopic)

479

3205

1.50

15.72

1.8

1.5

—

Retinal haemorrhage

140

3.70

15.63

1.9

1.3

—

Conduction disorders

359

1800

1.61

15.63

1.6

1.4

—

Haemorrhoids and perianal venous thrombosis

442

2902

1.52

15.58

1.5

1.4

—

Explicit fungal Sepsis, including avohilmo

6.41

15.58

1.6

1.3

—

Exposure to other specified factors

1304

8797

1.28

15.57

1.5

—

Chronic iridocyclitis

384

2.55

15.57

1.4

1.5

—

Abnormal weight loss

154

761

2.06

15.51

1.4

—

Pregnancy examination and test

271

968

1.76

15.48

1.3

1.4

—

Reactive arthropathies

145

701

2.11

15.48

1.4

—

Rash and other nonspecific skin eruption

156

775

2.05

15.47

1.6

1.5

—

Drug-induced hypoglycaemia without coma

114

4.07

15.45

1.7

1.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

190

1012

1.92

15.45

2.1

1.6

—

Artificial opening status

332

2.65

15.44

1.9

1.1

—

Pre-eclampsia or eclampsia

326

2020

1.63

15.42

1.6

1.3

—

Haemophagocytic lymphohistiocytosis

31.71

15.32

1.4

1.5

—

Lupus nephritis

14.07

15.30

1.4

1.6

—

Encephalitis

245

2.97

15.28

1.2

1.5

—

Conjunctivitis (acute, non atopic), including avohilmo

1578

7627

1.25

15.28

1.5

—

Migraine with aura

435

2885

1.52

15.21

1.3

1.4

—

Basal cell carcinoma

450

2021

1.53

15.19

1.6

1.4

—

Hypertension, portal

14.03

15.18

1.5

1.3

—

Diseases of salivary glands

486

3299

1.49

15.18

1.4

—

Spontaneous abortion

668

3184

1.42

15.17

1.4

—

Other abnormal findings of blood chemistry

348

2.60

15.09

1.4

—

Hypersensitivity angiitis

12.45

15.09

2.6

1.3

—

Rheumatoid arthritis

413

2392

1.54

15.09

1.3

1.4

—

Corns and callosities

109

475

2.35

15.09

2.1

1.4

—

Post-traumatic stress disorder

183

971

1.92

15.05

1.4

1.3

—

Open wound of ankle and foot

190

1020

1.90

15.05

1.8

1.4

—

Other encephalitis

232

3.01

14.93

1.2

1.5

—

Emphysema

110

483

2.32

14.93

1.4

—

Other disorders of iris and ciliary body

200

3.17

14.91

1.8

1.4

—

Late syphilis

104

4.20

14.89

2.4

1.4

—

Other disorders starting during childhood or adolecense, excluding more controls

128

572

2.20

14.86

2.4

1.7

—

Systemic sclerosis, icd10

150

3.54

14.86

1.4

—

Sulfasalazine

368

2367

1.57

14.80

1.3

1.4

—

Polymyalgia rheumatica

157

794

2.00

14.76

1.2

1.3

—

Other external causes of accidental injury

1275

4987

1.29

14.75

1.4

1.5

—

Small fibre neuropathy

212

3.09

14.74

1.7

1.4

—

Sicca syndrome [Sjögren]

124

576

2.19

14.70

1.2

1.3

—

Asthma, including avohilmo

1860

8372

1.23

14.62

1.4

1.5

—

Use of antiglaucoma preparations and miotics

419

2.40

14.59

1.7

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1458

7785

1.26

14.59

1.4

1.5

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

240

2.91

14.53

1.6

1.4

—

Malignant neoplasm of head and neck

105

457

2.34

14.51

1.2

1.5

—

Other and unspecified iridocyclitis

379

2.50

14.51

1.3

1.4

—

Cyst of kidney

108

477

2.31

14.50

1.9

1.3

—

Falls/tendency to fall

1723

6996

1.24

14.45

1.5

—

Dermatopolymyositis

4.31

14.42

1.4

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

4.17

14.39

1.1

1.2

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

12.20

14.29

1.3

1.8

—

Other diseases of lip and oral mucosa

613

4393

1.41

14.27

1.5

1.4

—

Prurigo nodularis

154

3.44

14.27

1.7

1.3

—

Gestational diabetes (for exclusion)

623

3055

1.42

14.18

1.4

—

Other headache syndromes

622

4456

1.40

14.18

1.3

1.5

—

Pulmonary oedema

4.48

14.17

2.3

1.4

—

Accidents

1269

4987

1.28

14.17

1.4

1.5

—

Injury, poisoning and certain other consequences of external causes

847

3150

1.36

14.15

1.5

1.4

—

Haemorrhage in early pregnancy

396

2540

1.53

14.12

1.4

1.3

—

Conjunctivitis

1215

7709

1.27

14.11

1.5

—

Intestinal malabsorption

366

2.50

14.10

1.9

1.4

—

Transport accidents

760

4685

1.36

14.03

1.5

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

587

4125

1.41

14.03

1.6

1.4

—

Exclusions for E4_PCOS_BROAD

301

1875

1.63

13.98

1.7

1.6

—

Lung diseases due to external agents

177

951

1.88

13.93

1.4

—

Carrier of infectious disease

198

3.10

13.91

1.7

1.4

—

Infarction of spleen

7.03

13.90

1.7

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

782

5634

1.35

13.88

1.5

—

Malignant neoplasm of head and neck, including Hilmo

121

569

2.16

13.87

1.3

1.5

—

Phobic anxiety disorders

264

1594

1.68

13.82

1.7

1.4

—

Carcinoma in situ of skin of other and unspecified parts of face

100

436

2.33

13.80

1.7

1.2

—

Malignant neoplasm of other and unspecified parts of biliary tract

4.82

13.67

1.1

1.3

—

Carcinoma in situ of skin of trunk

163

3.28

13.66

1.5

1.3

—

Pregnancy with abortive outcome

913

3593

1.33

13.65

1.3

—

Adverse effects, not elsewhere classified

335

2154

1.57

13.64

1.6

1.5

—

Chronic sinusitis

627

4539

1.39

13.63

1.4

1.5

—

Vasculitis limited to skin, not elsewhere classified

174

3.22

13.62

1.3

1.4

—

Reactive arthropathies, FINNGEN

118

555

2.17

13.61

1.3

1.5

—

Ventral hernia

313

1980

1.60

13.61

1.6

1.4

—

Atopic dermatitis

978

6002

1.30

13.60

1.4

1.5

—

Pre-eclampsia

303

1905

1.61

13.58

1.5

1.3

—

Dermatophytosis

208

1185

1.78

13.57

1.8

1.4

—

Malignant neoplasm of other connective and soft tissue

139

3.50

13.57

1.9

1.4

—

Diseases of the ear and mastoid process

1810

7443

1.22

13.54

1.5

1.4

—

Drug-induced polyneuropathy

4.66

13.46

1.5

1.7

—

Osteoporosis with pathological fracture (FG)

349

2.48

13.42

1.3

—

Rheumatoid arthritis, including avohilmo

476

3299

1.45

13.39

1.3

1.4

—

Drug-induced osteoporosis

4.43

13.38

1.5

1.3

—

Visual impairment including blindness (binocular or monocular)

104

469

2.26

13.31

1.8

1.4

—

Excessive, frequent and irregular menstruation

593

2245

1.42

13.28

1.4

—

Other and unspecified follicular disorders

347

2.49

13.23

1.9

1.4

—

Drug-induced systemic lupus erythematosus

6.08

13.17

1.3

1.5

—

Nonsuppurative otitis media, including avohilmo

589

3668

1.40

13.13

1.7

1.4

—

Nonalcoholic steatohepatitis

4.76

13.12

1.2

1.3

—

Recurrent and persistent haematuria

4.89

13.10

2.0

1.3

—

Retinal vascular disorders

144

738

1.98

13.10

1.7

1.3

—

Vascular disorders of the intestines

354

2.44

13.02

1.6

1.3

—

Infection due to other mycobacteria

4.50

13.01

1.5

1.3

—

Injuries to the thorax

638

4671

1.37

13.00

1.6

1.5

—

Mixed connective tissue disease

110

3.80

12.93

1.4

1.5

—

Erectile dysfunction

118

567

2.12

12.91

1.7

1.5

—

Chronic rhinitis, nasopharyngitis and pharyngitis

494

3478

1.43

12.79

1.4

1.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

403

2.36

12.79

2.3

1.6

—

Lack of expected normal physiological development

194

2.92

12.72

3.1

1.5

—

Erythema multiforme

166

3.20

12.69

1.3

1.4

—

Retinal vascular occlusion

142

733

1.96

12.67

1.7

1.3

—

Cardiac murmurs and other cardiac sounds

173

943

1.84

12.63

1.7

1.6

—

Membranous nephropathy

10.10

12.62

2.6

1.3

—

Aortic valve malfunction, age under 60 years

167

913

1.87

12.61

2.1

1.6

—

Inflammatory diseases of female pelvic organs

898

4718

1.31

12.60

1.4

1.3

—

Speech and linguistic disorders, excluding more controls

178

930

1.83

12.52

2.3

1.6

—

Symptoms and signs involving speech and voice

433

2988

1.46

12.52

1.3

1.4

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

100

456

2.23

12.47

1.3

1.5

—

Congenital malformations of the circulatory system

263

1586

1.63

12.46

2.0

1.7

—

Crohn's disease (strict) with PSC

18.38

12.40

1.3

1.4

—

Somatoform disorder

245

1497

1.66

12.38

1.3

1.4

—

Delirium, not induced by alcohol and other psychoactive substances

149

786

1.91

12.37

1.6

1.3

—

Hyperkinetic disorders, excluding more controls

282

1662

1.61

12.37

1.6

1.5

—

Syphilis

212

2.89

12.36

2.1

1.4

—

Syphilis, including avohilmo

212

2.89

12.36

2.1

1.4

—

Other follicular disorders

140

728

1.96

12.34

1.9

1.5

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

370

2.37

12.31

1.6

1.4

—

Seropositive rheumatoid arthritis

281

1767

1.59

12.26

1.3

1.4

—

Acute bronchiolitis

159

778

1.89

12.24

2.3

1.8

—

Personal history of malignant neoplasm

113

545

2.11

12.22

1.3

1.1

—

Malignant neoplasm of tonsil

4.29

12.20

1.3

1.5

—

Temporal arteritis

191

2.96

12.17

1.1

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1337

7080

1.24

12.13

1.5

1.4

—

Late syphilis, including avohilmo

125

3.53

12.13

2.4

1.4

—

Other and unspecified vasculitis limited to skin

155

3.21

12.10

1.3

1.4

—

Maternal care for known or suspected abnormality of pelvic organs

391

1778

1.50

12.08

1.3

1.4

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

165

896

1.85

12.07

1.8

1.7

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

227

2.83

12.07

2.9

1.6

—

Supervision of high-risk pregnancy

313

1202

1.58

12.06

1.3

1.4

—

Retention of urine

414

2295

1.47

12.00

1.6

1.4

—

Malignant neoplasm of tonsil and base of tongue

116

3.58

11.95

1.2

1.4

—

Other disorders of conjunctiva

189

1088

1.76

11.94

1.7

1.4

—

Hypothyroidism, other/unspecified

1292

6856

1.24

11.92

1.5

1.4

—

Disorders of continuity of bone

164

907

1.84

11.92

1.8

1.4

—

Bacterial, viral and other infectious agents, including avohilmo

163

901

1.84

11.90

2.0

1.6

—

Other (not insulin) diabetes medications

1333

6326

1.24

11.87

1.4

—

Haemolytic-uraemic syndrome

11.74

11.86

2.9

1.7

—

Fracture of foot, except ankle

404

2784

1.47

11.85

1.7

1.5

—

Obesity, other/unspecified

524

3782

1.40

11.82

1.5

1.4

—

Bacterial, viral and other infectious agents

152

824

1.88

11.82

2.1

1.6

—

Complications following infusion, transfusion and therapeutic injection

103

3.77

11.80

2.2

1.4

—

Atopic dermatitis, strict definition with reimbursement

537

3744

1.39

11.67

1.5

—

Acidosis

143

3.27

11.67

2.5

1.3

—

Speech therapy

337

2246

1.51

11.67

1.7

1.4

—

Malignant neoplasm of small intestine

113

3.56

11.65

2.0

1.4

—

Infection of intervertebral disc (pyogenic)

4.14

11.64

2.0

1.4

—

Rosacea

199

1172

1.72

11.63

1.6

1.4

—

Migraine without aura

361

2445

1.49

11.59

1.4

1.5

—

Malignant melanoma, including Hilmo

180

1030

1.76

11.58

1.5

1.4

—

Fracture of lumbar spine and pelvis

270

1712

1.59

11.57

1.6

1.4

—

False labour

467

2032

1.44

11.57

1.3

1.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

353

1983

1.50

11.46

1.4

—

Giant cell arteritis with polymyalgia rheumatica

198

2.85

11.42

1.1

1.3

—

Other and unspecified urticaria

311

2050

1.53

11.40

1.6

1.5

—

Seborrhoeic dermatitis

153

840

1.85

11.40

1.6

1.4

—

Retinal detachment with retinal break

168

948

1.80

11.40

1.7

1.4

—

Personality disorders, excluding more controls

411

2858

1.45

11.34

1.4

—

Postzoster neuralgia

4.13

11.33

1.4

1.3

—

conjunctival haemorrhage

108

528

2.08

11.33

1.6

1.4

—

Ulcerative proctitis

111

549

2.07

11.33

1.3

1.5

—

Infection due to other mycobacteria, including avohilmo

3.94

11.32

1.5

1.2

—

Other and unspecified effects of external causes

457

3256

1.42

11.19

1.5

—

Other symptoms and signs involving the nervous and musculoskeletal systems

591

4392

1.35

11.10

1.5

—

Colectomy operation

213

1295

1.66

11.03

1.4

—

Other disorders of bone

298

1961

1.54

11.03

1.6

1.4

—

Other sleep disorders

180

1048

1.74

11.00

1.4

1.5

—

Unspecific neurodegenerative disorder

171

1998

0.58

10.99

1.3

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.63

10.99

1.2

1.4

—

Abscess of anal and rectal regions

140

757

1.88

10.98

1.6

1.5

—

Polycystic ovarian syndrome, consortium definition

1015

4608

1.27

10.97

1.4

1.3

—

Pain in thoracic spine

233

1452

1.62

10.94

1.4

1.5

—

Benign neoplasm: Transverse colon

148

815

1.84

10.94

1.7

1.4

—

N06DA Anticholinesterases

119

1726

0.53

10.93

1.3

—

Use of anticholinesterases

119

1726

0.53

10.93

1.3

—

Excessive attrition of teeth

953

7487

1.27

10.89

1.8

1.4

—

Other and unspecified rosacea

137

738

1.89

10.87

1.6

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

477

2993

1.40

10.87

1.7

1.5

—

Stroke, excluding SAH

700

3833

1.32

10.86

1.6

1.4

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

12.31

10.84

1.5

1.2

—

Pneumonia derived septicemia

281

2.49

10.79

2.1

1.6

—

Generalized anxiety disorder

301

1993

1.53

10.78

1.3

1.4

—

Human immunodeficiency virus [HIV] disease, including avohilmo

178

2.94

10.75

1.1

1.5

—

Chronic viral hepatitis

105

520

2.07

10.74

1.3

1.5

—

Allergic asthma (mode), excluding more controls

315

2055

1.51

10.72

1.3

—

Need for immunization against other single infectious diseases

16.45

10.58

3.2

1.2

—

Neuromuscular dysfunction of bladder

129

688

1.90

10.56

1.8

1.3

—

Benign neoplasm: Stomach

125

660

1.92

10.55

1.6

1.3

—

Voice disturbances

347

2377

1.47

10.54

1.3

1.4

—

Malignant melanoma

161

919

1.77

10.51

1.5

1.4

—

Nonsuppurative otitis media

447

2776

1.41

10.50

1.8

1.4

—

Other disorders of eye and adnexa

225

1406

1.62

10.50

1.6

1.5

—

Injuries to unspecified part of trunk, limb or body region

160

915

1.77

10.45

1.8

1.5

—

Otitis media, unspecified

226

1302

1.62

10.41

2.1

1.5

—

Substance abuse, excluding more controls

797

5189

1.29

10.40

1.4

1.5

—

Malignant neoplasm, without specification of site, including Hilmo

202

2.71

10.39

1.2

1.3

—

Stroke, including SAH

745

4117

1.30

10.39

1.6

1.4

—

Other specified and unspecified retinal disorders

226

2.63

10.38

2.1

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

243

1548

1.58

10.38

1.5

1.3

—

Human immunodeficiency virus [HIV] disease

176

2.91

10.38

1.1

1.5

—

Malignant neoplasm of oropharynx

3.78

10.37

1.3

1.5

—

Other inflammation of eyelid

206

1263

1.65

10.37

1.6

1.4

—

Fracture of rib(s), sternum and thoracic spine

394

2775

1.43

10.31

1.5

1.4

—

Selective deficiency of immunoglobulin G [IgG] subclasses

4.67

10.30

1.3

1.6

—

Polyarteritis nodosa

5.62

10.28

1.4

1.3

—

Carcinoma in situ of skin of upper limb, including shoulder

133

3.18

10.28

1.6

1.3

—

Gangrene, not elsewhere classified

5.57

10.26

2.8

1.3

—

Preterm labour and delivery

340

2333

1.47

10.25

1.4

—

Other diseases of gallbladder

269

2.47

10.24

1.5

1.3

—

Duodenal ulcer

125

667

1.90

10.19

1.7

1.4

—

Congenital malformations of heart and great arteries

229

1404

1.61

10.19

2.1

1.7

—

Other and unspecified vascular occlusions

108

549

1.99

10.18

1.8

1.3

—

Other diseases of upper respiratory tract

1617

7044

1.20

10.17

1.4

1.5

—

Soft tissue disorders related to use, overuse and pressure

356

2469

1.45

10.14

1.5

1.4

—

Anosmia

4.08

10.13

1.4

1.1

—

Abnormal findings on antenatal screening of mother

154

880

1.78

10.13

1.4

1.3

—

Acute gastritis

483

2.06

10.10

1.4

—

Corneal ulcer

277

1831

1.53

10.09

1.7

1.4

—

Juvenile arthritis (FINNGEN)

485

2.07

10.08

1.8

1.6

—

Other symptoms and signs involving the circulatory and respiratory systems

102

511

2.03

10.06

1.8

1.4

—

COPD, hospital admission 2, with asthma infections

358

2134

1.45

10.04

1.5

1.4

—

Problems related to lifestyle

167

978

1.73

10.04

1.4

—

Diseases of external ear

497

3660

1.37

9.99

1.7

1.5

—

Other juvenile arthritis

440

2.13

9.99

1.7

1.6

—

Polyuria

275

1820

1.52

9.93

1.4

—

Polymyositis

4.96

9.93

1.6

1.4

—

Diseases of male genital organs

785

3062

1.30

9.93

1.7

1.6

—

Adult-onset Still disease

8.06

9.92

1.2

1.4

—

Unspecified misadventure during surgical and medical care

414

2.14

9.89

1.7

1.4

—

Panic disorder

258

1689

1.55

9.86

1.4

—

Cryoglobulinemia

17.66

9.82

1.5

—

Infections with a predominantly sexual mode of transmission, including avohilmo

687

4853

1.30

9.81

1.5

1.4

—

Female infertility

444

1908

1.41

9.74

1.3

1.4

—

Malignant neoplasm of tonsil, including Hilmo

3.61

9.74

1.3

1.4

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

290

1662

1.51

9.72

1.5

1.4

—

Other/unspecified reactive arthropathies

107

553

1.97

9.71

1.3

1.5

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.48

9.71

2.8

1.4

—

Excessive vomiting in pregnancy

132

730

1.84

9.71

1.3

—

Other diseases of oesophagus

119

637

1.89

9.65

1.6

1.4

—

Coeliac disease

185

1127

1.66

9.61

1.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

429

3066

1.39

9.61

1.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

139

769

1.81

9.60

2.4

1.8

—

Varicella [chickenpox], including avohilmo

109

570

1.96

9.59

2.0

1.7

—

Spondylopathies (FG)

203

1266

1.62

9.59

1.3

1.5

—

Traction detachment of retina

4.47

9.55

2.7

1.3

—

COPD related to multimorbidity

432

2637

1.39

9.55

1.5

1.4

—

Other epidermal thickening

342

2.24

9.51

1.8

1.4

—

Open wound of lower leg

230

1480

1.57

9.51

1.9

1.5

—

Other disorders of optic [2nd] nerve and visual pathways

108

565

1.95

9.48

1.8

1.5

—

Malignant neoplasm of oropharynx, including Hilmo

114

3.26

9.43

1.6

1.4

—

Maternal care for known or suspected malpresentation of fetus

295

1416

1.50

9.39

1.3

1.4

—

Allergic asthma (mode)

315

2115

1.46

9.36

1.3

1.4

—

Malignant neoplasm of small intestine, including Hilmo

157

2.87

9.35

1.9

1.4

—

Viral agents as the cause of diseases classified to other chapters

192

2.70

9.33

2.2

1.6

—

Diseases of tongue

397

2.12

9.29

1.8

1.3

—

Complications of other internal prosthetic devices, implants and grafts

251

2.44

9.27

1.9

1.4

—

Malignant neoplasm of mesothelium and soft tissue

227

2.52

9.26

1.8

1.3

—

Myositis

175

2.77

9.26

1.7

1.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

233

1513

1.56

9.25

1.4

1.6

—

Fissure and fistula of anal and rectal regions

312

2151

1.46

9.23

1.4

—

Valvular operations

162

964

1.70

9.18

1.7

1.5

—

Pneumothorax

501

1.99

9.17

1.7

1.4

—

Ocular pain

137

780

1.78

9.17

1.6

1.5

—

Cytomegaloviral pneumonitis

14.51

9.13

1.8

1.3

—

Dermatographic urticaria

112

601

1.90

9.10

1.5

1.4

—

Other immunodeficiencies

3.56

9.08

1.6

1.7

—

Malnutrition

189

2.69

9.07

2.2

1.8

—

Dizziness and giddiness

1017

6438

1.23

9.05

1.4

—

Psoriatic and enteropathic arthropathies

158

939

1.70

9.04

1.3

1.5

—

Other and unspecified disorders of skin and subcutaneous tissue

456

2.03

9.03

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

258

1722

1.51

9.02

1.5

1.6

—

Allergic purpura

249

2.44

9.02

1.9

1.5

—

Autoimmune hyperthyroidism

429

2.06

9.01

1.3

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

144

2.93

9.01

1.2

1.4

—

Attention to artificial openings

218

2.52

9.01

1.8

1.3

—

Certolizumab pegol

167

2.80

8.99

1.1

1.4

—

Sickle-cell disorders

10.57

8.98

2.2

1.3

—

Other shoulder lesions

143

829

1.75

8.97

1.4

—

Malignant melanoma of skin, including Hilmo

146

850

1.73

8.97

1.5

1.4

—

Otitis externa, unspecified

184

1141

1.63

8.96

1.7

1.5

—

Malignant neoplasm of eye, brain and central nervous system

312

2.26

8.95

1.3

1.5

—

Migraine with aura and triptan purchases

284

1938

1.48

8.94

1.2

1.4

—

Melanocytic naevi of lower limb, including hip

365

2.16

8.91

1.7

1.4

—

Other nutritional anaemias

4.84

8.90

1.9

1.4

—

Presence of other devices

235

1515

1.54

8.90

1.6

1.1

—

Amenorrhoea

130

737

1.79

8.86

1.3

1.4

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

227

2.50

8.85

2.1

1.6

—

Diseases of the myoneural junction and muscle

162

976

1.68

8.82

1.4

1.5

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

214

1125

1.57

8.81

1.4

1.5

—

Diplopia

177

1091

1.64

8.81

1.4

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

120

666

1.83

8.77

1.6

1.3

—

Anuria and oliguria

5.04

8.73

2.1

1.6

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

240

2.43

8.73

1.4

—

Other peripheral vascular diseases

112

609

1.87

8.73

1.3

—

Hordeolum and other deep inflammation of eyelid

103

546

1.92

8.72

1.7

1.4

—

Pyogenic arthritis

483

1.98

8.69

1.8

1.5

—

Malignant melanoma of skin

122

681

1.81

8.69

1.5

—

COPD

506

3088

1.34

8.68

1.5

1.4

—

Acne

231

1514

1.54

8.68

1.8

1.4

—

Benign neoplasm: Caecum

134

771

1.76

8.65

1.3

1.4

—

Other bacterial agents as the cause of diseases classified to other chapters

3.85

8.59

2.0

1.5

—

Morphin

110

3.17

8.59

1.2

1.3

—

Spondylopathies

1011

4871

1.23

8.58

1.4

1.5

—

Injury of unspecified body region

116

642

1.84

8.56

2.0

1.4

—

Sequelae of other external causes

445

2.01

8.55

1.8

1.4

—

Amputation of thigh

137

2.90

8.53

2.6

1.3

—

Thyrotoxicosis, other and/or unspecified

271

1849

1.48

8.53

1.4

—

Campylobacter enteritis

213

2.51

8.50

1.6

1.4

—

Shoulder lesions

974

4745

1.23

8.47

1.5

1.4

—

Malignant neoplasm of brain

250

2.37

8.45

1.3

1.5

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.09

8.45

1.6

1.3

—

Thyroiditis, ILD-related definition

165

1011

1.65

8.44

1.5

1.4

—

Female infertility, cervical, vaginal, other or unspecified origin

400

1854

1.39

8.41

1.3

1.4

—

Oesophagitis

373

2.10

8.41

1.5

1.4

—

Disseminated intravascular coagulation [defibrination syndrome]

8.29

8.34

3.0

1.3

—

Respiratory disorders in diseases classified elsewhere

3.40

8.34

1.6

1.3

—

Viral meningitis, including avohilmo

349

2.14

8.31

1.3

1.4

—

Intestinal adhesions without obstruction

104

561

1.88

8.31

1.5

1.4

—

Hydrocele

158

961

1.66

8.31

1.9

1.5

—

Other inflammation of eyelid, including avohilmo

682

5389

1.27

8.29

1.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.59

8.28

1.5

1.3

—

Infections with a predominantly sexual mode of transmission

490

3705

1.33

8.24

1.6

1.4

—

Status post-ami

253

1290

1.50

8.20

1.6

1.3

—

Other surgical follow-up care

241

2.38

8.19

1.6

1.3

—

Clear cell adenocarcinoma of kidney

266

2.30

8.18

1.7

1.4

—

Other endocrine disorders

114

611

1.83

8.16

2.7

1.9

—

Other symptoms and signs involving cognitive functions and awareness

563

3849

1.30

8.14

1.3

1.4

—

Family history of certain disabilities and chronic diseases leading to disablement

440

1.99

8.12

1.6

1.2

—

Acne vulgaris

180

1139

1.60

8.09

1.8

1.4

—

Pneumococcal septicemia

281

2.26

8.08

2.0

1.5

—

Tuberculosis, IBD comorbidity

372

2.07

8.05

1.3

—

Hyperhidrosis

200

2.50

8.04

1.4

—

Other disorders of pigmentation

320

2.17

8.04

1.6

1.4

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

160

2.74

8.03

1.1

1.5

—

Malignant neoplasm of pancreas, including Hilmo

427

1.99

8.01

1.1

1.4

—

Abnormal involuntary movements

186

1189

1.58

8.00

1.4

1.5

—

Ovarian cyst

486

2087

1.34

8.00

1.4

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

739

5868

1.25

7.99

1.7

1.5

—

Allergic bronchopulmonary aspergillosis (ABPA)

10.24

7.98

2.4

1.3

—

Sequelae of cerebrovascular disease

380

2370

1.38

7.97

1.5

1.4

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

290

2033

1.44

7.96

1.4

1.3

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

161

2.72

7.94

1.1

1.5

—

Selective deficiency of immunoglobulin A [IgA]y

4.74

7.91

1.5

1.4

—

Cerebral aneurysm, nonruptured

114

644

1.79

7.89

1.6

1.4

—

Degenerative macular diseases

124

717

1.75

7.88

1.5

1.3

—

Dentofacial anomalies [including malocclusion]

1085

7063

1.21

7.85

1.5

—

Abnormal findings in nipple discharge synovial fluid wound secretions

117

3.03

7.83

1.5

—

Malignant neoplasm, without specification of site

127

2.88

7.83

1.1

1.2

—

Secondary polycythaemia

162

2.67

7.78

1.6

1.4

—

Postprocedural disorders of digestive system, not elsewhere classified

228

2.38

7.78

1.6

1.4

—

Nail disorders

131

774

1.72

7.76

1.7

1.5

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

174

1102

1.59

7.76

1.2

1.5

—

Varicella [chickenpox]

469

1.94

7.76

2.0

1.6

—

Vitamin deficiency, wide

358

2.08

7.76

1.5

1.4

—

Vitamin deficiency

358

2.08

7.76

1.5

1.4

—

Respiratory conditions due to other external agents

112

3.03

7.74

1.4

1.3

—

Folate deficiency anaemia

3.87

7.74

1.6

1.4

—

Other prurigo

3.86

7.73

2.1

1.3

—

Disorders of muscles

148

904

1.66

7.71

1.5

—

Acute laryngitis and tracheitis

205

1330

1.53

7.70

1.7

1.4

—

Bipolar affective disorders

289

2038

1.43

7.70

1.2

1.4

—

Degeneration of macula and posterior pole

480

2811

1.32

7.69

1.6

1.3

—

Calcinosis cutis

11.17

7.68

2.2

1.3

—

Glaucoma

619

4133

1.28

7.68

1.6

1.4

—

Tuberculosis, wide, including avohilmo

407

1.99

7.65

1.3

—

Fitting and adjustment of other devices

314

1971

1.41

7.64

1.5

1.2

—

Rapidly progressive nephritic syndrome

10.96

7.64

1.6

1.3

—

Abnormalities of gait and mobility

153

945

1.64

7.62

1.5

—

Ischaemic Stroke, excluding all haemorrhages

620

3583

1.28

7.62

1.6

1.4

—

Selective serotonin reuptake inhibitors

1459

6458

1.18

7.61

1.3

1.5

—

Medical abortion

813

3548

1.25

7.60

1.3

—

Disorders of iron metabolism

119

2.96

7.59

1.5

—

Scleritis and episcleritis

500

1.89

7.59

1.6

1.4

—

Contact with and exposure to communicable diseases

534

4125

1.30

7.59

1.5

—

Tick-borne viral encephalitis, including avohilmo

4.70

7.58

1.0

1.3

—

Other keratitis

173

1103

1.59

7.57

1.7

1.4

—

Medical treatment for female infertility

328

2349

1.40

7.56

1.3

1.4

—

Dissociative [conversion] disorders

329

2.11

7.52

1.1

1.4

—

Other complications of labour and delivery, not elsewhere classified

225

1344

1.50

7.51

1.3

—

Other chronic obstructive pulmonary disease

475

2961

1.32

7.50

1.5

1.4

—

Polyhydramnios

432

1.96

7.50

1.4

—

Other arthrosis

626

3299

1.28

7.50

1.4

—

Heartburn

143

872

1.66

7.49

1.5

1.4

—

Hypertension, Pulmonary Arterial

3.92

7.48

1.3

1.4

—

Malignant neoplasm of endocrine gland, including Hilmo

101

560

1.83

7.45

1.6

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

1406

8120

1.17

7.43

1.4

1.5

—

Otitis externa

330

2396

1.39

7.42

1.7

1.5

—

Other disorders starting during childhood or adolescence

129

763

1.71

7.42

2.4

1.9

—

Multiple gestation

139

845

1.67

7.41

1.3

1.4

—

Macular pucker

167

1061

1.59

7.40

1.5

1.3

—

Acquired pure red cell aplasia [erythroblastopenia]

7.95

7.40

1.3

—

Thyrotoxicosis

317

2287

1.40

7.39

1.4

—

Methotrexate

157

983

1.61

7.39

1.3

1.4

—

Familial hypercholesterolemia

152

944

1.62

7.39

1.7

1.4

—

Alzheimer disease, including avohilmo

148

1632

0.62

7.36

1.3

1.2

—

Carcinoma in situ of skin of lower limb, including hip

3.22

7.32

1.6

1.2

—

Specific development disorders of scholastic skills

111

626

1.78

7.32

2.5

1.8

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

109

624

1.77

7.26

1.4

1.5

—

Tuberculosis, wide

401

1.97

7.26

1.3

—

Other aneurysm

340

2.06

7.25

2.5

1.3

—

Malignant neoplasm of brain, including Hilmo

347

2.05

7.25

1.3

1.5

—

Malignant neoplasm of nasal cavity and sinuses

6.92

7.24

1.2

1.3

—

Unstable angina pectoris

354

2037

1.37

7.24

1.5

1.3

—

Other specified/unspecified soft tissue disorders

294

2.14

7.21

1.5

1.3

—

Other salmonella infections

249

2.25

7.20

1.3

1.4

—

Bullous disorders

389

1.99

7.20

1.7

1.4

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

128

768

1.69

7.19

1.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

447

3415

1.32

7.17

1.8

1.4

—

Drug-induced osteoporosis with pathological fracture

112

2.96

7.16

1.5

1.3

—

Polycythaemia vera

163

2.56

7.14

1.4

1.3

—

Panniculitis, unspecified

3.75

7.12

1.4

1.5

—

Disorders of optic nerve and visual pathways

145

902

1.63

7.09

1.6

1.5

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

13.32

7.08

3.4

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

595

2742

1.28

7.07

1.3

1.4

—

Injuries to the knee and lower leg

1771

8327

1.15

7.06

1.5

—

Disorders of globe

141

2.68

7.03

2.0

1.3

—

Atopic dermatitis, strict definition

513

3914

1.29

7.02

1.5

—

Speech and linguistic disorders

190

1209

1.53

6.98

2.4

1.7

—

All dysplastic lesions of the vulva

292

2.13

6.96

1.7

1.3

—

Benign neoplasm: Pancreas

172

2.50

6.92

1.3

—

Type 1 diabetes, definitions combined

178

1166

1.54

6.89

2.1

1.6

—

Alzheimer disease

122

1428

0.61

6.88

1.3

1.2

—

Arthropathy in ulcerative colitis

104

3.00

6.86

1.1

1.4

—

Enteropathic arthropathies

179

2.47

6.86

1.2

1.5

—

Impotence

482

1.86

6.83

1.9

1.5

—

Noninflammatory disorders of female genital tract

574

2257

1.28

6.83

1.3

1.4

—

Seminoma of testis, including Hilmo

3.65

6.82

1.5

1.4

—

Malignant neoplasm of bone and articular cartilage

3.65

6.82

1.4

—

Arthrosis

879

3964

1.22

6.80

1.4

—

Unspecified fall

703

5601

1.24

6.80

1.5

—

Disorders of synovium and tendon

732

5052

1.23

6.79

1.5

1.4

—

Cardiomyopathy in other diseases

6.82

6.78

1.1

1.3

—

KRA_PSY_EATING, excluding more controls

152

958

1.59

6.77

1.5

1.4

—

Intracranial trauma

848

4720

1.22

6.73

1.4

1.5

—

Benign neoplasm: Sigmoid colon

212

1449

1.47

6.72

1.6

1.4

—

Type of accident

409

3117

1.32

6.72

1.7

1.4

—

Mixed hyperlipidaemia

263

2.17

6.72

1.7

1.4

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

145

2.64

6.71

1.6

1.4

—

Injuries to the hip and thigh

591

4220

1.26

6.71

1.6

1.4

—

Nonspecific lymphadenitis

492

1.84

6.71

1.3

1.5

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

100

3.02

6.70

2.0

1.5

—

Acne, including avohilmo

450

2804

1.31

6.70

1.6

1.4

—

Twin gestation

133

823

1.64

6.66

1.3

1.4

—

Other (seronegative) rheumatoid arthritis, wide

212

1452

1.47

6.66

1.3

1.4

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

111

2.87

6.65

1.6

1.4

—

Asthma and allergy, excluding more controls

184

1209

1.52

6.65

1.3

—

Right hemicolectomy

338

2.01

6.63

1.5

1.4

—

Lung cancer and mesothelioma

161

878

1.56

6.63

1.3

1.4

—

Nocardiosis, including avohilmo

22.83

6.62

1.8

1.0

—

Nocardiosis

22.83

6.62

1.8

1.0

—

Other and unspecified glaucoma

387

1.93

6.59

1.9

1.3

—

Injuries to the head

1659

8576

1.15

6.58

1.5

—

Alzheimer’s disease, strict definition

1194

0.56

6.58

1.4

1.2

—

Essential (haemorrhagic) thrombocythaemia

207

2.31

6.58

1.2

1.3

—

Dementia, including avohilmo

251

2401

0.71

6.56

1.3

1.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

3.75

6.54

1.4

1.5

—

202

2.34

6.53

2.1

1.5

—

Maternal care for cervical incompetence

300

2.08

6.52

1.4

1.3

—

Dementia

226

2204

0.70

6.52

1.2

1.4

—

Papulosquamous disorders

501

3937

1.28

6.51

1.5

1.4

—

Adhesive capsulitis of shoulder

195

1321

1.49

6.49

1.7

1.4

—

Degenerative diseases of the nervous system

158

1730

0.65

6.46

1.4

1.3

—

Biliary cirrhosis, NAS

7.84

6.45

1.7

1.5

—

Female infertility, associated with anovulation

142

901

1.60

6.44

1.3

1.4

—

Persistent mood disorders

251

1786

1.42

6.43

1.5

1.4

—

Lichen simplex chronicus

242

2.19

6.41

1.7

1.4

—

Restrictive cardiomyopathy

6.38

6.40

2.2

1.4

—

Moderate visual impairment, binocular

154

2.51

6.39

1.6

1.4

—

Autonomic disorders

179

2.41

6.38

1.7

1.5

—

Juvenile rheumatoid arthirtis

186

2.38

6.33

1.6

1.5

—

Benign neoplasm: Ascending colon

160

1046

1.54

6.33

1.5

1.4

—

Type 1 diabetes, strict (exclude DM2)

176

1174

1.51

6.30

2.1

1.6

—

Primary hyperparathyroidism

121

742

1.65

6.29

1.6

1.3

—

Other salmonella infections, including avohilmo

318

2.02

6.27

1.3

1.4

—

Henoch-Schönlein purpura nephritis (HSPN)

5.70

6.25

3.1

1.2

—

Other nonthrombocytopenic purpura

3.65

6.25

1.6

1.4

—

Other and unspecified disorders of autonomic nervous system

4.44

6.25

1.3

1.4

—

Hypermobility syndrome

504

1.80

6.24

1.2

1.4

—

Persons encountering health services in circumstances related to reproduction

863

4817

1.21

6.20

1.6

—

Benign neoplasm: Duodenum

163

2.45

6.19

1.4

—

Intracerebral haemorrhage

125

776

1.62

6.17

1.6

1.4

—

Malignant neoplasm of endocrine gland

483

1.80

6.17

1.6

1.5

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.90

6.16

1.3

1.4

—

COPD, hospital admissions

473

3122

1.28

6.15

1.5

1.4

—

Iron deficiency

356

1.96

6.15

1.4

1.5

—

Asthma and allergy

184

1230

1.49

6.14

1.3

—

Hypersensitivity pneumonitis due to organic dust

105

2.85

6.14

1.5

1.4

—

Crossbite

148

883

1.57

6.11

2.5

1.8

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

6.28

6.09

1.1

1.3

—

Hypoparathyroidism

221

2.21

6.09

1.4

1.3

—

Concussion

728

4641

1.22

6.08

1.4

1.5

—

Malignant neoplasm of eye and adnexa, including Hilmo

3.23

6.07

1.3

1.5

—

Follow-up examination after treatment for malignant neoplasms

529

1.75

6.06

1.4

1.3

—

Epilepsy

401

3083

1.30

6.06

1.5

1.6

—

Rheumatism, unspecified

144

929

1.56

6.06

1.2

1.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

100

572

1.73

6.06

1.9

1.6

—

Viral meningitis

330

1.98

6.04

1.3

1.4

—

Superficial injury of lower leg

375

2870

1.31

6.03

1.5

1.4

—

Disorders of optic nerve, not elsewhere classified

141

2.55

6.02

1.5

1.4

—

Malignant neoplasm of respiratory system and intrathoracic organs

177

985

1.50

6.01

1.3

1.4

—

Barrett oesophagus

344

1.95

6.01

1.3

1.4

—

Disturbance of activity and attention

279

1999

1.38

5.99

1.7

1.5

—

COPD, early/later onset

476

3147

1.27

5.94

1.5

1.4

—

Bell's palsy

151

990

1.54

5.94

1.7

1.4

—

Coronary artery bypass grafting

237

1246

1.42

5.93

1.8

1.3

—

Absence of one kidney, including avohilmo

4.35

5.93

2.3

1.5

—

Urolithiasis

388

2990

1.30

5.93

1.7

1.4

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

6.81

5.92

1.1

1.4

—

Etanercept

104

625

1.69

5.91

1.4

1.5

—

Volvulus

154

2.45

5.91

1.5

1.4

—

Seronegative rheumatoid arthritis

121

755

1.62

5.88

1.3

1.4

—

Paracetamol or NSAID medication

268

970

1.40

5.88

1.5

1.7

—

Injuries to the wrist and hand

1496

8666

1.15

5.87

1.5

—

Other noninflammatory disorders of vulva and perineum

135

867

1.57

5.84

1.5

1.4

—

Other endophthalmitis

5.50

5.84

2.0

1.4

—

Single delivery by caesarean section

297

1245

1.37

5.83

1.3

1.5

—

Psoriasis

371

2850

1.31

5.82

1.5

—

Alport

7.71

5.80

3.8

1.4

—

Cardiomyopathies, Secondary/extrinsic

4.08

5.80

1.6

1.3

—

Tuberculosis of other organs, strict, including avohilmo

108

2.74

5.80

1.6

1.4

—

Trigger finger

179

1223

1.48

5.77

1.9

1.4

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

176

2.36

5.74

2.1

1.8

—

Malignant neoplasm of pancreas

342

1.92

5.73

1.1

1.4

—

Overexertion and strenuous or repetitive movements

140

911

1.55

5.73

1.4

1.5

—

Gestational [pregnancy-induced] hypertension

352

2687

1.32

5.71

1.4

1.3

—

Corticotropin deficiency

3.33

5.70

1.4

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS